# Barings BDC, Inc.: Form 10-Q for the period ended Jun 30, 2022

- Company: [Barings BDC, Inc.](/companies/bbdc.md) (CIK 1379785)
- Form: 10-Q
- Filed: 2022-08-09
- Accepted by EDGAR: Aug 9, 2022, 16:18 ET
- Period: 2022-06-30
- Accession: 0001379785-22-000032
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1379785/000137978522000032/bbdc-20220630.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1379785/000137978522000032/

## Management's discussion and analysis

As filed, 109,736 characters.

The following discussion is designed to provide a better understanding of our unaudited consolidated financial statements for the three and six months ended June 30, 2022, including a brief discussion of our business, key factors that impacted our performance and a summary of our operating results. The following discussion should be read in conjunction with the Unaudited Consolidated Financial Statements and the notes thereto included in Item 1 of this Quarterly Report on Form 10-Q, and the Consolidated Financial Statements and notes thereto and Management’s Discussion and Analysis of Financial Condition and Results of Operations contained in our Annual Report on Form 10-K for the year ended December 31, 2021. Historical results and percentage relationships among any amounts in the financial statements are not necessarily indicative of trends in operating results for any future periods.

### Forward-Looking Statements

Some of the statements in this Quarterly Report constitute forward-looking statements because they relate to future events or our future performance or financial condition. Forward-looking statements may include, among other things, statements as to our future operating results, our business prospects and the prospects of our portfolio companies, the impact of the investments that we expect to make, the ability of our portfolio companies to achieve their objectives, our expected financings and investments, the adequacy of our cash resources and working capital, and the timing of cash flows, if any, from the operations of our portfolio companies. Words such as "expect," "anticipate," "target," "goals," "project," "intend," "plan," "believe," "seek," "estimate," "continue," "forecast," "may," "should," "potential," variations of such words, and similar expressions indicate a forward-looking statement, although not all forward-looking statements include these words. Readers are cautioned that the forward-looking statements contained in this Quarterly Report are only predictions, are not guarantees of future performance, and are subject to risks, events, uncertainties and assumptions that are difficult to predict. Our actual results could differ materially from those implied or expressed in the forward-looking statements for any reason, including the items discussed herein, in Item 1A entitled "Risk Factors" in Part I of our Annual Report on Form 10-K for the year ended December 31, 2021 and in Item 1A entitled "Risk Factors" in Part II of our subsequently filed Quarterly Reports on Form 10-Q. Other factors that could cause our actual results and financial condition to differ materially include, but are not limited to, changes in political, economic or industry conditions, the interest rate environment or conditions affecting the financial and capital markets, including with respect to changes from the impact of the COVID-19 pandemic; the length and duration of the COVID-19 outbreak in the United States as well as worldwide and the magnitude of the economic impact of that outbreak; the effect of the COVID-19 pandemic on our business prospects and the prospects of our portfolio companies, including our and their ability to achieve our respective objectives; the effect of the disruptions caused by the COVID-19 pandemic on our ability to continue to effectively manage our business and on the availability of equity and debt capital and our use of borrowed money to finance a portion of our investments; risks associated with possible disruption due to terrorism in our operations or the economy generally; and future changes in laws or regulations and conditions in our operating areas. These statements are based on our current expectations, estimates, forecasts, information and projections about the industry in which we operate and the beliefs and assumptions of our management as of the date of filing of this Quarterly Report. We assume no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, unless we are required to do so by law. Although we undertake no obligation to revise or update any forward-looking statements, whether as a result of new information, future events or otherwise, you are advised to consult any additional disclosures that we may make directly to you or through reports that we in the future may file with the SEC, including annual reports on Form 10-K, quarterly reports on Form 10-Q and current reports on Form 8-K.

### Overview of Our Business

We are a Maryland corporation incorporated on October 10, 2006. In August 2018, in connection with the closing of an externalization transaction through which Barings LLC (“Barings”) agreed to become our external investment adviser, we entered into an investment advisory agreement (the “Original Advisory Agreement”) and an administration agreement (the “Administration Agreement”) with Barings. In connection with the completion of our acquisition of MVC Capital, Inc., a Delaware corporation, on December 23, 2020 (the “MVC Acquisition”), we entered into an amended and restated investment advisory agreement (the “Amended and Restated Advisory Agreement”) with Barings on December 23, 2020, following approval of the Amended and Restated Advisory Agreement by our stockholders at our December 23, 2020 special meeting of stockholders. The terms of the Amended and Restated Advisory Agreement became effective on January 1, 2021. In connection with the completion of the Sierra Acquisition (as defined below), on February 25, 2022, we entered into a second amended and restated investment advisory agreement (the “New Barings BDC Advisory Agreement”) with the Adviser. Under the terms of the New Barings BDC Advisory Agreement and the Administration Agreement, Barings serves as our investment adviser and administrator and manages our investment portfolio and performs (or oversees, or arranges for, the performance of) the administrative services necessary for our operation.

An externally-managed BDC generally does not have any employees, and its investment and management functions are provided by an outside investment adviser and administrator under an advisory agreement and administration agreement. Instead of directly compensating employees, we pay Barings for investment management and administrative services pursuant to the terms of an investment advisory agreement and an administration agreement. Under the terms of the New Barings BDC Advisory Agreement, the fees paid to Barings for managing our affairs are determined based upon an objective and fixed formula, as compared with the subjective and variable nature of the costs associated with employing management and employees in an internally-managed BDC structure, which include bonuses that cannot be directly tied to Company performance because of restrictions on incentive compensation under the Investment Company Act of 1940, as amended (the “1940 Act”).

Beginning in August 2018, Barings shifted our investment focus to invest in syndicated senior secured loans, bonds and other fixed income securities. Since that time, Barings has transitioned our portfolio to primarily senior secured private debt investments in well-established middle-market businesses that operate across a wide range of industries. Barings’ existing SEC co-investment exemptive relief under the 1940 Act (the “Exemptive Relief”) permits us and Barings’ affiliated private and SEC-registered funds to co-invest in Barings-originated loans, which allows Barings to efficiently implement its senior secured private debt investment strategy for us.

Barings employs fundamental credit analysis, and targets investments in businesses with relatively low levels of cyclicality and operating risk. The holding size of each position will generally be dependent upon a number of factors including total facility size, pricing and structure, and the number of other lenders in the facility. Barings has experience managing levered vehicles, both public and private, and will seek to enhance our returns through the use of leverage with a prudent approach that prioritizes capital preservation. Barings believes this strategy and approach offers attractive risk/return with lower volatility given the potential for fewer defaults and greater resilience through market cycles. A significant portion of our investments are expected to be rated below investment grade by rating agencies or, if unrated would be rated below investment grade if they were rated. Below investment grade securities, which are often referred to as “junk,” have predominantly speculative characteristics with respect to the issuer’s capacity to pay interest and repay principal.

We generate revenues in the form of interest income, primarily from our investments in debt securities, loan origination and other fees and dividend income. Fees generated in connection with our debt investments are recognized over the life of the loan using the effective interest method or, in some cases, recognized as earned. Our senior secured, middle-market, private debt investments generally have terms of between five and seven years. Our senior secured, middle-market, first lien private debt investments generally bear interest between LIBOR (or the applicable currency rate for investments in foreign currencies) plus 450 basis points and LIBOR plus 650 basis points per annum. Our subordinated middle-market, private debt investments generally bear interest between LIBOR (or the applicable currency rate for investments in foreign currencies) plus 700 basis points and LIBOR plus 900 basis points per annum if floating rate, and between 8% and 15% if fixed rate. From time to time, certain of our investments may have a form of interest, referred to as payment-in-kind, or PIK, interest, which is not paid currently but is instead accrued and added to the loan balance and paid at the end of the term.

As of June 30, 2022 and December 31, 2021, the weighted average yield on the principal amount of our outstanding debt investments other than non-accrual debt investments was approximately 7.6% and 7.2%, respectively. The weighted average yield on the principal amount of all of our outstanding debt investments (including non-accrual debt investments) was approximately 7.2% and 6.9% as of June 30, 2022 and December 31, 2021, respectively.

### Sierra Income Corporation Acquisition

On February 25, 2022, we completed our acquisition of Sierra Income Corporation, a Maryland corporation (“Sierra”), pursuant to the terms and conditions of that certain Agreement and Plan of Merger (the “Sierra Merger Agreement”), dated as of September 21, 2021, with Sierra, Mercury Acquisition Sub, Inc., a Maryland corporation and our direct wholly owned subsidiary (“Sierra Acquisition Sub”), and Barings. To effect the acquisition, Sierra Acquisition Sub merged with and into Sierra, with Sierra surviving the merger as our wholly owned subsidiary (the “First Sierra Merger”). Immediately thereafter, Sierra merged with and into us, with Barings BDC, Inc. as the surviving company (the “Second Sierra Merger” and, together with the First Sierra Merger, the “Sierra Merger”).

Pursuant to the Sierra Merger Agreement, each share of Sierra common stock, par value $0.001 per share (the “Sierra Common Stock”), issued and outstanding immediately prior to the effective time of the First Sierra Merger (other than shares of Sierra Common Stock issued and outstanding immediately prior to the effective time of the First Sierra Merger that were held by a subsidiary of Sierra or held, directly or indirectly, by us or Sierra Acquisition Sub) was converted into the right to receive (i) an amount in cash from Barings, without interest, equal to $0.9783641, and (ii) 0.44973 shares of the our common stock, plus any cash in lieu of fractional shares. As a result of the Sierra Merger, former Sierra stockholders received approximately 46.0 million shares of our common stock for their shares of Sierra Common Stock.

In connection with the Sierra Acquisition, on February 25, 2022, following the closing of the Sierra Merger, we entered into (1) the New Barings BDC Advisory Agreement, and (2) a credit support agreement (the “Sierra Credit Support Agreement”) with Barings, pursuant to which Barings has agreed to provide credit support to us in the amount of up to $100.0 million relating to the net cumulative realized and unrealized losses on the acquired Sierra investment portfolio over a 10-year period. See “Note 2. Agreements and Related Party Transactions” and “Note. 6 Derivative Instruments” in the Notes to our Consolidated Financial Statements included in this Quarterly Report on Form 10-Q for more information.

In addition, in connection with the closing of the Sierra Merger, our board of directors (the “Board”) affirmed our commitment to purchase in open-market transactions, pursuant to Rule 10b-18 under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and subject to our compliance with our covenant and regulatory requirements, shares of our common stock in an aggregate amount of up to $30,000,000 at then-current market prices at any time the shares of our common stock trade below 90% of our then most recently disclosed net asset value per share during the 12-month period commencing on April 1, 2022.

### COVID-19 Developments

The spread of the Coronavirus and the COVID-19 pandemic, and the related effect on the U.S. and global economies, has had adverse consequences for the business operations of some of our portfolio companies but no longer adversely affects our operations and the operations of Barings, including with respect to us. Barings continues to monitor the COVID-19 situation globally and is prepared to adapt office working patterns as required to ensure the safety of its employees and clients who visit Barings office locations. Barings’ cybersecurity policies are applied consistently when working remotely or in the office.

While we have been carefully monitoring the COVID-19 pandemic and its impact on our business and the business of our portfolio companies, we have continued to fund our existing debt commitments. In addition, we have continued to make and originate, and expect to continue to make and originate, new loans.

We will continue to monitor the situation relating to the COVID-19 pandemic and guidance from U.S. and international authorities, including federal, state and local public health authorities and may take additional actions based on their recommendations. In these circumstances, there may be developments outside our control requiring us to adjust our plan of operation. As such, given the dynamic nature of this situation, we cannot reasonably estimate the impacts of COVID-19 on our financial condition, results of operations or cash flows in the future. However, to the extent our portfolio companies are adversely impacted by the effects of the COVID-19 pandemic, it may have a material adverse impact on our future net investment income, the fair value of our portfolio investments, our financial condition and the results of operations and financial condition of our portfolio companies.

### Relationship with Our Adviser, Barings

Our investment adviser, Barings, a wholly-owned subsidiary of Massachusetts Mutual Life Insurance Company, is a leading global asset management firm and is registered with the SEC as an investment adviser under the Investment Advisers Act of 1940, as amended. Barings’ primary investment capabilities include fixed income, private credit, real estate, equity, and alternative investments. Subject to the overall supervision of the Board, Barings’ Global Private Finance Group (“BGPF”) manages our day-to-day operations, and provides investment advisory and management services to us. BGPF is part of Barings’ $274.4 billion Global Fixed Income Platform that invests in liquid, private and structured credit. BGPF manages private funds and separately managed accounts, along with multiple public vehicles.

Among other things, Barings (i) determines the composition of our portfolio, the nature and timing of the changes therein and the manner of implementing such changes; (ii) identifies, evaluates and negotiates the structure of the investments made by us; (iii) executes, closes, services and monitors the investments that we make; (iv) determines the securities and other assets that we will purchase, retain or sell; (v) performs due diligence on prospective portfolio companies and (vi) provides us with such other investment advisory, research and related services as we may, from time to time, reasonably require for the investment of our funds.

Under the terms of the Administration Agreement, Barings performs (or oversees, or arranges for, the performance of) the administrative services necessary for our operation, including, but not limited to, office facilities, equipment, clerical, bookkeeping and record keeping services at such office facilities and such other services as Barings, subject to review by the Board, will from time to time determine to be necessary or useful to perform its obligations under the Administration Agreement. Barings also, on our behalf and subject to the Board’s oversight, arranges for the services of, and oversees, custodians, depositories, transfer agents, dividend disbursing agents, other stockholder servicing agents, accountants, attorneys, underwriters, brokers and dealers, corporate fiduciaries, insurers, banks and such other persons in any such other capacity deemed to be necessary or desirable. Barings is responsible for the financial and other records that we are required to maintain and will prepare all reports and other materials required to be filed with the SEC or any other regulatory authority.

### Stockholder Approval of Reduced Asset Coverage Ratio

On July 24, 2018, our stockholders voted at a special meeting of stockholders (the “2018 Special Meeting”) to approve a proposal to authorize us to be subject to a reduced asset coverage ratio of at least 150% under the 1940 Act. As a result of the stockholder approval at the 2018 Special Meeting, effective July 25, 2018, our applicable asset coverage ratio under the 1940 Act has been decreased to 150% from 200%. As a result, we are permitted under the 1940 Act to incur indebtedness at a level which is more consistent with a portfolio of senior secured debt. As of June 30, 2022, our asset coverage ratio was 181.4%.

### Portfolio Investment Composition

The total value of our investment portfolio was $2,389.1 million as of June 30, 2022, as compared to $1,800.6 million as of December 31, 2021. As of June 30, 2022, we had investments in 294 portfolio companies with an aggregate cost of $2,439.1 million. As of December 31, 2021, we had investments in 212 portfolio companies with an aggregate cost of $1,787.8 million. As of both June 30, 2022 and December 31, 2021, none of our portfolio investments represented greater than 10% of the total fair value of our investment portfolio.

As of June 30, 2022 and December 31, 2021, our investment portfolio consisted of the following investments:

*($ in thousands)*

| June 30, 2022: | Cost | Percentage of Total Portfolio | Fair Value | Percentage of Total Portfolio |
| --- | ---: | ---: | ---: | ---: |
| Senior debt and 1st lien notes | $1,582,312 | 65% | $1,550,204 | 65% |
| Subordinated debt and 2nd lien notes | 370,972 | 15 | 315,809 | 13 |
| Structured products | 82,515 | 3 | 70,385 | 3 |
| Equity shares | 206,407 | 9 | 268,622 | 11 |
| Equity warrants | 174 | — | 92 | — |
| Investment in joint ventures / PE fund | 196,687 | 8 | 183,964 | 8 |
|  | $2,439,067 | 100% | $2,389,076 | 100% |
| **December 31, 2021:** |  |  |  |  |
| Senior debt and 1st lien notes | $1,217,899 | 68% | $1,221,598 | 68% |
| Subordinated debt and 2nd lien notes | 253,551 | 14 | 240,037 | 13 |
| Structured products | 37,055 | 2 | 40,271 | 2 |
| Equity shares | 145,791 | 8 | 154,477 | 9 |
| Equity warrants | 1,111 | — | 1,107 | — |
| Investment in joint ventures / PE fund | 132,417 | 8 | 143,104 | 8 |
|  | $1,787,824 | 100% | $1,800,594 | 100% |

### Investment Activity

During the six months ended June 30, 2022, we made 48 new investments totaling $495.2 million, purchased $442.2 million of investments as part of the Sierra Acquisition, made investments in existing portfolio companies totaling $173.5 million and made additional investments in joint venture equity portfolio companies totaling $13.8 million. We had 21 loans repaid totaling $178.3 million, received $22.5 million of portfolio company principal payments and received $35.5 million of return of capital from our joint ventures. In addition, we sold $101.7 million of loans, recognizing a net realized loss on these transactions of $6.1 million, and sold $132.3 million of middle-market portfolio company debt investments to one of our joint ventures and realized a loss on these transactions of $0.2 million. We received proceeds related to the sale of equity investments totaling $1.7 million and recognized a net realized loss on such sales totaling $0.7 million. Lastly, we exchanged a debt investment totaling $13.8 million in one portfolio company for equity totaling $13.9 million and realized a loss on such exchange of $0.8 million.

During the six months ended June 30, 2021, we made 40 new investments totaling $390.9 million, made investments in

existing portfolio companies totaling $112.9 million, made a net new joint venture equity investment totaling $5.5 million and

additional investments in joint venture equity portfolio companies totaling $30.0 million. We had 13 loans repaid at par totaling

$92.6 million and received $25.6 million of portfolio company principal payments. In addition, we sold $57.0 million of loans, recognizing a net realized gain on these transactions of $2.4 million, and sold $250.4 million of middle-market portfolio company debt investments to one of our joint ventures and realized a gain on these transactions of $1.4 million. Lastly, we received proceeds related to the sale of equity investments totaling $5.9 million and recognized a net realized loss on such sales totaling $0.5 million.

Total portfolio investment activity for the six months ended June 30, 2022 and 2021 was as follows:

| Six Months Ended June 30, 2022: ($ in thousands) | Senior Debt and 1st Lien Notes | Subordinated Debt and 2nd Lien Notes | Structured Products | Equity Shares | Equity Warrants | Investments in Joint Ventures / PE Fund | Total |
| --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Fair value, beginning of period | $1,221,598 | $240,037 | $40,271 | $154,477 | $1,107 | $143,104 | $1,800,594 |
| New investments | 539,897 | 80,753 | 7,060 | 55,006 | — | 13,797 | 696,513 |
| Investments acquired in Sierra merger | 235,770 | 66,662 | 46,666 | 7,065 | 72 | 85,963 | 442,198 |
| Proceeds from sales of investments | (227,678) | (14,754) | (5,389) | (1,607) | (250) | (35,490) | (285,168) |
| Loan origination fees received | (10,371) | (1,121) | — | — | — | — | (11,492) |
| Principal repayments received | (175,265) | (22,610) | (2,888) | — | — | — | (200,763) |
| Payment-in-kind interest | 2,125 | 8,939 | — | — | — | — | 11,064 |
| Accretion of loan premium/discount | 1,146 | 83 | 11 | — | — | — | 1,240 |
| Accretion of deferred loan origination revenue | 4,339 | 974 | — | — | — | — | 5,313 |
| Realized gain (loss) | (5,551) | (1,505) | — | 153 | (760) | — | (7,663) |
| Unrealized appreciation (depreciation) | (35,806) | (41,649) | (15,346) | 53,528 | (77) | (23,410) | (62,760) |
| Fair value, end of period | $1,550,204 | $315,809 | $70,385 | $268,622 | $92 | $183,964 | $2,389,076 |

| Six Months Ended June 30, 2021: ($ in thousands) | Senior Debt and 1st Lien Notes | Subordinated Debt and 2nd Lien Notes | Structured Products | Equity Shares | Equity Warrants | Investments in Joint Ventures / PE Fund | Short-term Investments | Total |
| --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Fair value, beginning of period | $1,171,250 | $138,767 | $32,509 | $44,651 | $1,300 | $41,760 | $65,558 | $1,495,795 |
| New investments | 420,633 | 75,316 | — | 8,260 | 163 | 38,200 | 217,559 | 760,131 |
| Proceeds from sales of investments | (291,705) | (8,771) | (6,823) | (5,972) | — | (2,675) | (272,542) | (588,488) |
| Loan origination fees received | (9,037) | (987) | — | — | — | — | — | (10,024) |
| Principal repayments received | (91,580) | (24,847) | (2,307) | — | — | — | — | (118,734) |
| Payment-in-kind interest | 1,565 | 7,570 | — | — | — | — | — | 9,135 |
| Accretion of loan premium/discount | 1,267 | 2,528 | 27 | — | — | — | — | 3,822 |
| Accretion of deferred loan origination revenue | 3,228 | 285 | — | — | — | — | — | 3,513 |
| Realized gain (loss) | 3,176 | (24) | 652 | (436) | — | — | (1) | 3,367 |
| Unrealized appreciation (depreciation) | 10,068 | (2,970) | 777 | 5,499 | 25 | 3,192 | — | 16,591 |
| Fair value, end of period | $1,218,865 | $186,867 | $24,835 | $52,002 | $1,488 | $80,477 | $10,574 | $1,575,108 |

### Non-Accrual Assets

Generally, when interest and/or principal payments on a loan become past due, or if we otherwise do not expect the borrower to be able to service its debt and other obligations, we will place the loan on non-accrual status and will generally cease recognizing interest income on that loan for financial reporting purposes until all principal and interest have been brought current through payment or due to a restructuring such that the interest income is deemed to be collectible. As of June 30, 2022, we had seven portfolio companies with investments on non-accrual, the fair value of which was $20.0 million, which comprised 0.8% of the total fair value of our portfolio, and the cost of which was $71.1 million, which comprised 2.9% of the total cost of our portfolio. As of December 31, 2021, we had two portfolio companies with investments on non-accrual, the fair value of which was $36.0 million, which comprised 2.0% of the total fair value of our portfolio, and the cost of which was $50.9 million, which comprised 2.9% of the total cost of our portfolio.

A summary of our non-accrual assets as of June 30, 2022 is provided below:

#### 1888 Industrial Services, LLC

In connection with the Sierra Acquisition, we purchased our debt and equity investments in 1888 Industrial Services, LLC, or 1888. The 1888 first lien senior secured term loan is on non-accrual status and as a result, under U.S. GAAP, we will not recognize interest income on our first lien senior secured term loan in 1888 for financial reporting purposes. As of June 30, 2022, the cost and fair value of our first lien senior secured term loan in 1888 was $0.4 million and zero, respectively.

#### Black Angus Steakhouse, LLC

In connection with the Sierra Acquisition, we purchased our debt and equity investments in Black Angus Steakhouse, LLC, or Black Angus. The Black Angus PIK term loan is on non-accrual status and as a result, under U.S. GAAP, we will not recognize interest income on our PIK term loan in Black Angus for financial reporting purposes. As of June 30, 2022, both the cost and fair value of our PIK term loan in Black Angus was $9.6 million.

#### Charming Charlie LLC

In connection with the Sierra Acquisition, we purchased our debt and equity investments in Charming Charlie, LLC, or Charming Charlie. Charming Charlie is on non-accrual status and as a result, under U.S. GAAP, we will not recognize interest income on our debt investments in Charming Charlie for financial reporting purposes. As of June 30, 2022, both the cost and fair value of our debt investments in Charming Charlie was zero.

#### Custom Alloy Corporation

In connection with the MVC Acquisition, we purchased our debt investment in Custom Alloy Corporation, or Custom Alloy. During the quarter ended December 31, 2021, we placed our debt investment in Custom Alloy on non-accrual status. As a result, under U.S. GAAP, we will not recognize interest income on our debt investment in Custom Alloy for financial reporting purposes. As of June 30, 2022, the cost of our debt investment in Custom Alloy was $46.4 million and the fair value of such investment was $5.6 million.

#### Holland Acquisition Corp.

In connection with the Sierra Acquisition, we purchased our debt investment in Holland Acquisition Corp., or Holland. Holland is on non-accrual status and as a result, under U.S. GAAP, we will not recognize interest income on our debt investments in Holland for financial reporting purposes. As of June 30, 2022, both the cost and fair value of our debt investments in Holland was zero.

#### Legal Solutions Holdings

In connection with the MVC Acquisition, we purchased our debt investment in Legal Solutions Holdings, or Legal Solutions. During the quarter ended September 30, 2021, we placed our debt investment in Legal Solutions on non-accrual status. As a result, under U.S. GAAP, we will not recognize interest income on our debt investment in Legal Solutions for financial reporting purposes. As of June 30, 2022, the cost of our debt investment in Legal Solutions was $10.1 million and the fair value of such investment was zero.

#### Path Medical LLC

In connection with the Sierra Acquisition, we purchased our debt and equity investments in Path Medical LLC, or Path Medical. Path Medical is on non-accrual status and as a result, under U.S. GAAP, we will not recognize interest income on our debt investments in Path Medical for financial reporting purposes. As of June 30, 2022, the cost and fair value of our debt investments in Path Medical was $4.6 million and $4.7 million, respectively.

### Results of Operations

### Comparison of the three and six months ended June 30, 2022 and June 30, 2021

Operating results for the three and six months ended June 30, 2022 and 2021 were as follows:

*(in thousands)*

|  | Three Months Ended June 30, 2022 | Three Months Ended June 30, 2021 | Six Months Ended June 30, 2022 | Six Months Ended June 30, 2021 |
| --- | ---: | ---: | ---: | ---: |
| Total investment income | $55,592 | $33,153 | $99,350 | $63,747 |
| Total operating expenses | 23,818 | 18,595 | 48,563 | 34,833 |
| **Net investment income before taxes** | **31,774** | **14,558** | **50,787** | **28,914** |
| Income taxes, including excise tax provision | — | — | 6 | (18) |
| **Net investment income after taxes** | **31,774** | **14,558** | **50,781** | **28,932** |
| Net realized gains (losses) | (10,223) | 343 | (11,665) | 2,182 |
| Net unrealized appreciation (depreciation) | (44,654) | 14,409 | (41,188) | 20,683 |
| Net realized and unrealized gains (losses) on investments, credit support agreements and foreign currency borrowings | (54,877) | 14,752 | (52,853) | 22,865 |
| Provision for taxes | (1,890) | (2) | (1,890) | (1) |
| **Net increase in net assets resulting from operations** | **$(24,993)** | **$29,308** | **$(3,962)** | **$51,796** |

Net increases or decreases in net assets resulting from operations can vary substantially from period to period due to various factors, including recognition of realized gains and losses and unrealized appreciation and depreciation. As a result, quarterly comparisons of net changes in net assets resulting from operations may not be meaningful.

#### Investment Income

*($ in thousands)*

| Investment income: | Three Months Ended June 30, 2022 | Three Months Ended June 30, 2021 | Six Months Ended June 30, 2022 | Six Months Ended June 30, 2021 |
| --- | ---: | ---: | ---: | ---: |
| Total interest income | $40,784 | $26,819 | $72,854 | $52,034 |
| Total dividend income | 7,246 | 395 | 14,939 | 466 |
| Total fee and other income | 5,072 | 2,568 | 6,268 | 4,701 |
| Total payment-in-kind interest income | 2,474 | 3,371 | 5,273 | 6,545 |
| Interest income from cash | 16 | — | 16 | 1 |
| Total investment income | $55,592 | $33,153 | $99,350 | $63,747 |

The change in total investment income for the three and six months ended June 30, 2022, as compared to the three and six months ended June 30, 2021, was primarily due to an increase in the average size of our portfolio, increased dividends from portfolio companies and joint venture investments and an increase in acceleration of unamortized OID and unamortized loan origination fee income associated with repayments of loans. The increase in the average size of our portfolio was largely due to the increased middle-market investment opportunities and the investments acquired as part of the Sierra Acquisition. This increase was partially offset by a decrease in payment-in-kind (“PIK”) interest income. For the three and six months ended June 30, 2022, dividends from portfolio companies and joint venture investments were $7.2 million and $14.9 million, respectively, as compared to $0.4 million and $0.5 million, respectively, for the three and six months ended June 30, 2021. The amount of our outstanding debt investments was $2,162.5 million as of June 30, 2022, as compared to $1,463.6 million as of June 30, 2021. This increase is in part due to the acquisition of investment assets in the Sierra Acquisition. The weighted average yield on the principal amount of our outstanding debt investments other than non-accrual debt investments was 7.6% as of June 30, 2022, as compared to 7.4% as of June 30, 2021. For the three and six months ended June 30, 2022, acceleration of unamortized OID income and unamortized loan origination fees totaled $2.9 million and $3.1 million, respectively, as compared to $2.2 million and $2.6 million, respectively, for the three and six months ended June 30, 2021. For the three and six months ended June 30, 2022, PIK interest income was $2.5 million and $5.3 million, respectively, as compared to $3.4 million and $6.5 million, respectively, for the three and six months ended June 30, 2021.

#### Operating Expenses

*($ in thousands)*

| Operating expenses: | Three Months Ended June 30, 2022 | Three Months Ended June 30, 2021 | Six Months Ended June 30, 2022 | Six Months Ended June 30, 2021 |
| --- | ---: | ---: | ---: | ---: |
| Interest and other financing fees | $13,168 | $7,994 | $24,829 | $15,279 |
| Base management fees | 7,381 | 4,891 | 13,253 | 8,821 |
| Incentive management fees | — | 3,510 | 4,754 | 6,232 |
| General and administrative expenses | 3,269 | 2,200 | 5,727 | 4,501 |
| Total operating expenses | $23,818 | $18,595 | $48,563 | $34,833 |

#### Interest and Other Financing Fees

Interest and other financing fees during the three and six months ended June 30, 2022 were attributable to borrowings under the February 2019 Credit Facility, the August 2025 Notes, the November Notes, the February Notes and the November 2026 Notes (each as defined below under “Liquidity and Capital Resources”). Interest and other financing fees during the three and six months ended June 30, 2021 were attributable to borrowings under the February 2019 Credit Facility, the August 2025 Notes, the November Notes and the February Notes. The increase in interest and other financing fees for the three and six months ended June 30, 2022 as compared to the three and six months ended June 30, 2021, was primarily attributable to the issuance of the November 2026 Notes and increased borrowings under the February 2019 Credit Facility.

#### Base Management Fees

Under the terms of the New Barings BDC Advisory Agreement, we pay Barings a base management fee (the “Base Management Fee”), quarterly in arrears on a calendar quarter basis. The Base Management Fee is calculated based on the average value of our gross assets, excluding cash and cash equivalents, at the end of the two most recently completed calendar quarters prior to the quarter for which such fees are being calculated. Base Management Fees for any partial month or quarter are appropriately pro-rated. See Note 2 to our Unaudited Consolidated Financial Statements for additional information regarding the terms of the New Barings BDC Advisory Agreement (and, from January 1, 2021 to February 25, 2022, the terms of the Amended and Restated Advisory Agreement) and the fee arrangements thereunder. For the three and six months ended June 30, 2022, the amount of Base Management Fee incurred was approximately $7.4 million and $13.3 million, respectively. For the three and six months ended June 30, 2021, the amount of Base Management Fee incurred was approximately $4.9 million and $8.8 million, respectively. The increase in the Base Management Fee for the three and six months ended June 30, 2022 versus the corresponding 2021 periods is primarily related to the average value of gross assets increasing from $1,565.2 million as of the end of the two most recently completed calendar quarters prior to June 30, 2021 to $2,361.8 million as of the end of the two most recently completed calendar quarters prior to June 30, 2022. For both the three and six months ended June 30, 2022 and 2021, the Base Management Fee rate was 1.250%.

#### Incentive Fee

Under the New Barings BDC Advisory Agreement (and, from January 1, 2021 to February 25, 2022, pursuant to the terms of the Amended and Restated Advisory Agreement), we pay Barings an incentive fee. A portion of the incentive fee is based on our income and a portion is based on our capital gains. The income-based fee will be determined and paid quarterly in arrears based on the amount by which (x) the aggregate pre-incentive fee net investment income in respect of the current calendar quarter and the eleven preceding calendar quarters beginning with the calendar quarter that commences on or after January 1, 2021, as the case may be (or the appropriate portion thereof in the case of any of our first eleven calendar quarters that commences on or after January 1, 2021) exceeds (y) the hurdle amount as calculated for the same period. See Note 2 to our Unaudited Consolidated Financial Statements for additional information regarding the terms of the New Barings BDC Advisory Agreement and the fee arrangements thereunder. For the three and six months ended June 30, 2022, the amount of income-based fee incurred was zero and $4.8 million, respectively, as compared to $3.5 million and $6.2 million, respectively, for the three and six months ended June 30, 2021. The Income-Based Fee is subject to a cap (the “Incentive Fee Cap”). During the three months ended June 30, 2022, the incentive fee was zero due to the the Incentive Fee Cap. The Incentive Fee Cap in any quarter is an amount equal to (a) 20% of the Cumulative Pre-Incentive Fee Net Return during the relevant Trailing Twelve Quarters less (b) the aggregate Income-Based Fee that were paid to the Adviser in the preceding eleven calendar quarters (or portion thereof) comprising the relevant Trailing Twelve Quarters. See Note 2 to our Unaudited Consolidated Financial Statements for additional information regarding the terms of the Incentive Fee Cap.

#### General and Administrative Expenses

We entered into the Administration Agreement with Barings in August 2018. Under the terms of the Administration Agreement, Barings performs (or oversees, or arranges for, the performance of) the administrative services necessary for our operations. We will reimburse Barings for the costs and expenses incurred by it in performing its obligations and providing personnel and facilities under the Administration Agreement in an amount to be negotiated and mutually agreed to by us and Barings quarterly in arrears; provided that the agreed-upon quarterly expense amount will not exceed the amount of expenses that would otherwise be reimbursable by us under the Administration Agreement for the applicable quarterly period, and Barings will not be entitled to the recoupment of any amounts in excess of the agreed-upon quarterly expense amount. See Note 2 to our Unaudited Consolidated Financial Statements for additional information regarding the Administration Agreement. For the three and six months ended June 30, 2022, the amount of administration expense incurred and invoiced by Barings for expenses was approximately $0.9 million and $1.8 million, respectively. For the three and six months ended June 30, 2021, the amount of administration expense incurred and invoiced by Barings for expenses was approximately $0.5 million and $1.0 million, respectively. In addition to expenses incurred under the Administration Agreement, general and administrative expenses include Board fees, D&O insurance costs, as well as legal, valuation and accounting expenses.

#### Net Realized Gains (Losses)

Net realized gains (losses) during the three and six months ended June 30, 2022 and 2021 were as follows:

*($ in thousands)*

| Net realized gain (losses): | Three Months Ended June 30, 2022 | Three Months Ended June 30, 2021 | Six Months Ended June 30, 2022 | Six Months Ended June 30, 2021 |
| --- | ---: | ---: | ---: | ---: |
| Non-Control / Non-Affiliate investments | $(6,701) | $553 | $(6,951) | $3,444 |
| Affiliate investments | — | — | 101 | (77) |
| Control investments | (813) | — | (813) | — |
| Net realized gains (losses) on investments | (7,514) | 553 | (7,663) | 3,367 |
| Foreign currency transactions | (2,709) | (210) | (4,002) | (1,185) |
| Net realized gains (losses) | $(10,223) | $343 | $(11,665) | $2,182 |

During the three months ended June 30, 2022, we recognized net realized losses totaling $10.2 million, which consisted primarily of a net loss on our loan portfolio of $6.7 million, a $0.8 million loss on the exchange of a debt investment in one portfolio company for equity, and a net loss on foreign currency transactions of $2.7 million. During the six months ended June 30, 2022, we recognized net realized losses totaling $11.7 million, which consisted primarily a net loss on our loan portfolio of $6.9 million, a $0.8 million loss on the exchange of a debt investment in one portfolio company for equity, and a net loss on foreign currency transactions of $4.0 million.

During the three months ended June 30, 2021, we recognized net realized gains totaling $0.3 million, which consisted primarily of a net gain on our loan portfolio of $0.6 million partially offset by a net loss on foreign currency transactions of $0.2 million. During the six months ended June 30, 2021, we recognized net realized gains totaling $2.2 million, which consisted primarily of a net gain on our loan portfolio of $3.4 million partially offset by a net loss on foreign currency transactions of $1.2 million.

#### Net Unrealized Appreciation (Depreciation)

Net unrealized appreciation (depreciation) during the three and six months ended June 30, 2022 and 2021 was as follows:

*($ in thousands)*

| Net unrealized appreciation (depreciation): | Three Months Ended June 30, 2022 | Three Months Ended June 30, 2021 | Six Months Ended June 30, 2022 | Six Months Ended June 30, 2021 |
| --- | ---: | ---: | ---: | ---: |
| Non-Control / Non-Affiliate investments | $(65,428) | $4,304 | $(94,016) | $9,661 |
| Affiliate investments | (13,435) | 7,087 | (440) | 9,532 |
| Control investments | 17,050 | 1,368 | 31,696 | (2,602) |
| Net unrealized appreciation (depreciation) on investments | (61,813) | 12,759 | (62,760) | 16,591 |
| Credit support agreements | (13,361) | 2,300 | (13,760) | 700 |
| Foreign currency transactions | 30,520 | (650) | 35,332 | 3,392 |
| Net unrealized appreciation (depreciation) | $(44,654) | $14,409 | $(41,188) | $20,683 |

104

During the three months ended June 30, 2022, we recorded net unrealized depreciation totaling $44.7 million, consisting of net unrealized depreciation on our current portfolio of $62.7 million, unrealized depreciation of $5.7 million on the MVC credit support agreement with Barings, unrealized depreciation of $7.7 million on the Sierra credit support agreement with Barings, net of unrealized appreciation reclassification adjustments of $0.9 million related to the net realized gains on the sales / repayments of certain investments and net unrealized appreciation related to foreign currency transactions of $30.5 million. The net unrealized depreciation on our current portfolio of $62.7 million was driven primarily by credit or fundamental performance of investments of $5.8 million, the impact of foreign currency exchange rates on investments of $24.5 million and broad market moves for investments of $32.4 million.

During the six months ended June 30, 2022, we recorded net unrealized depreciation totaling $41.2 million, consisting of net unrealized depreciation on our current portfolio of $62.6 million, net unrealized depreciation of $6.1 million on the MVC credit support agreement with Barings, net unrealized depreciation of $7.7 million on the Sierra credit support agreement with Barings and unrealized depreciation reclassification adjustments of $0.1 million related to the net realized gains on the sales / repayments of certain investments, net of unrealized appreciation related to foreign currency transactions of $35.3 million. The net unrealized depreciation on our current portfolio of $62.6 million was driven primarily by the impact of foreign currency exchange rates on investments of $29.2 million and broad market moves for investments of $55.4 million, partially offset by credit or fundamental performance of investments of $22.0 million.

During the three months ended June 30, 2021, we recorded net unrealized appreciation totaling $14.4 million, consisting of net unrealized appreciation on our current portfolio of $12.1 million, unrealized appreciation of $2.3 million on the credit support agreement with Barings and unrealized appreciation reclassification adjustments of $0.7 million related to the net realized gains on the sales / repayments of certain investments, net of unrealized depreciation related to foreign currency transactions of $0.6 million. The net unrealized appreciation on the current portfolio of $12.1 million was driven primarily by broad market moves for investments of $7.8 million and the credit or fundamental performance of investments of $5.1 million, partially offset by the impact of foreign currency exchange rates on investments of $0.8 million.

During the six months ended June 30, 2021, we recorded net unrealized appreciation totaling $20.7 million, consisting of net unrealized appreciation on our current portfolio of $18.5 million, unrealized appreciation related to foreign currency transactions of $3.4 million and unrealized appreciation of $0.7 million on the credit support agreement with Barings, net of unrealized depreciation reclassification adjustments of $1.9 million related to the net realized gains on the sales / repayments of certain investments. The net unrealized appreciation on the current portfolio of $18.5 million was driven primarily by broad market moves for investments of $21.7 million and the credit or fundamental performance of investments of $2.0 million, partially offset by the impact of foreign currency exchange rates on investments of $5.2 million.

### Liquidity and Capital Resources

We believe that our current cash and foreign currencies on hand, our available borrowing capacity under the February 2019 Credit Facility and our anticipated cash flows from operations will be adequate to meet our cash needs for our daily operations for at least the next twelve months. This “Liquidity and Capital Resources” section should be read in conjunction with “COVID-19 Developments” above, as well as with the notes to our Unaudited Consolidated Financial Statements.

#### Cash Flows

For the six months ended June 30, 2022, we experienced a net increase in cash in the amount of $113.5 million. During that period, our operating activities used $12.7 million in cash, consisting primarily of purchases of portfolio investments of $708.7 million, partially offset by net cash acquired from the acquisition of Sierra of $101.9 million and proceeds from sales or repayments of portfolio investments totaling $603.2 million. In addition, our financing activities provided net cash of $126.2 million, consisting of net borrowings under the February 2019 Credit Facility (as defined below under “Financing Transactions”) of $184.7 million, partially offset by dividends paid in the amount of $41.5 million and share repurchases of $15.1 million. As of June 30, 2022, we had $197.8 million of cash and foreign currencies on hand.

For the six months ended June 30, 2021, we experienced a net decrease in cash in the amount of $61.8 million. During that period, our operating activities used $139.0 million in cash, consisting primarily of purchases of portfolio investments of $538.0 million and purchases of short-term investments of $217.6 million, partially offset by proceeds from sales of portfolio investments totaling $322.4 million and sales of short-term investments of $272.5 million. In addition, our financing activities provided $77.2 million of cash, consisting of net proceeds of $149.8 million from the issuance of the February Notes (as defined below under “Financing Transactions”), partially offset by net repayments under the February 2019 Credit Facility of $47.1 million and dividends paid in the amount of $25.5 million. As of June 30, 2021, we had $30.7 million of cash and foreign currencies on hand.

#### Financing Transactions

#### February 2019 Credit Facility

On February 21, 2019, we entered into a senior secured credit facility with ING Capital LLC (“ING”), as administrative agent, and the lenders party thereto (as amended, restated and otherwise modified from time to time, the “February 2019 Credit Facility”). The initial commitments under the February 2019 Credit Facility total $800.0 million. Effective on November 4, 2021, we increased aggregate commitments under the February 2019 Credit Facility to $875.0 million from $800.0 million pursuant to the accordion feature under the February 2019 Credit Facility, which allows for an increase in the total commitments to an aggregate of $1.2 billion subject to certain conditions and the satisfaction of specified financial covenants. Effective on February 25, 2022, we increased aggregate commitments under the February 2019 Credit Facility to $965.0 million from $875.0 million pursuant to the accordion feature under the February 2019 Credit Facility, and the allowance for an increase in the total commitments increased to $1.5 billion from $1.2 billion subject to certain conditions and the satisfaction of specified financial covenants. Effective on April 1, 2022, we increased aggregate commitments under the February 2019 Credit Facility to $1.1 billion from $965.0 million pursuant to the accordion feature under the February 2019 Credit Facility, which allows for an increase in the total commitments to an aggregate of $1.5 billion subject to certain conditions and the satisfaction of specified financial covenants. We can borrow foreign currencies directly under the February 2019 Credit Facility. The February 2019 Credit Facility, which is structured as a revolving credit facility, is secured primarily by a material portion of our assets and guaranteed by certain of our subsidiaries. Following the termination on June 30, 2020 of Barings BDC Senior Funding I, LLC’s (“BSF”) credit facility entered into in August 2018 with Bank of America, N.A. (the “August 2018 Credit Facility”), BSF became a subsidiary guarantor and its assets secure the February 2019 Credit Facility. The revolving period of the February 2019 Credit Facility ends on February 21, 2024, followed by a one-year repayment period with a maturity date of February 21, 2025.

Borrowings denominated in U.S. Dollars under the February 2019 Credit Facility bear interest, subject to our election, on a per annum basis equal to (i) the alternate base rate plus 1.25% (or 1.00% for so long as we maintain an investment grade credit rating) or (ii) the term Secured Overnight Financing Rate (“SOFR”) plus 2.25% (or 2.00% for so long as we maintain an investment grade credit rating) plus a credit spread adjustment of 0.10% for borrowings with an interest period of one month, 0.15% for borrowings with an interest period of three months or 0.25% for borrowings with an interest period of six months. The alternate base rate is equal to the greatest of (i) the prime rate, (ii) the federal funds rate plus 0.5%, (iii) the Overnight Bank Funding Rate plus 0.5%, (iv) one-month term SOFR plus 1.0% plus a credit spread adjustment of 0.10% and (v) 1.0%. For borrowings denominated in certain foreign currencies other than Australian dollars, the applicable currency rate for the foreign currency as defined in the credit agreement plus 2.00% (or 2.25% if we no longer maintain an investment grade credit rating) or for borrowings denominated in Australian dollars, the applicable Australian dollars Screen Rate, plus 2.20% (or 2.45% if we no longer maintain an investment grade credit rating).

In addition, we pay a commitment fee of (i) 0.5% per annum on undrawn amounts if the unused portion of the February 2019 Credit Facility is greater than two-thirds of total commitments or (ii) 0.375% per annum on undrawn amounts if the unused portion of the February 2019 Credit Facility is equal to or less than two-thirds of total commitments. In connection with entering into the February 2019 Credit Facility, we incurred financing fees of approximately $6.4 million, which will be amortized over the life of the February 2019 Credit Facility.

As of June 30, 2022, we were in compliance with all covenants under the February 2019 Credit Facility and had U.S. dollar borrowings of $537.5 million outstanding under the February 2019 Credit Facility with an interest rate of 3.198% (one month SOFR of 1.098%), borrowings denominated in Swedish kronas of 12.8kr million ($1.2 million U.S. dollars) with an interest rate of 2.250% (one month STIBOR of 0.250%), borrowings denominated in British pounds sterling of £77.6 million ($94.2 million U.S. dollars) with an interest rate of 2.972% (one month SONIA of 0.972%), borrowings denominated in Australian dollars of A$53.1 million ($36.5 million U.S. dollars) with an interest rate of 2.780% (one month AUD Screen Rate of 0.780%) and borrowings denominated in Euros of €138.6 million ($144.9 million U.S. dollars) with an interest rate of 2.000% (one month EURIBOR of 0.000%). The borrowings denominated in foreign currencies were translated into U.S. dollars based on the spot rate at the relevant balance sheet date. The impact resulting from changes in foreign exchange rates on the February 2019 Credit Facility borrowings is included in "Net unrealized appreciation (depreciation) - foreign currency transactions" in our Unaudited Consolidated Statements of Operations.

The fair values of the borrowings outstanding under the February 2019 Credit Facility are based on a market yield approach and current interest rates, which are Level 3 inputs to the market yield model. As of June 30, 2022, the total fair value of the borrowings outstanding under the February 2019 Credit Facility was $814.4 million. See Note 5 to our Unaudited Consolidated Financial Statements for additional information regarding the February 2019 Credit Facility.

#### August 2025 Notes

On August 3, 2020, we entered into a Note Purchase Agreement (the “August 2020 NPA”) with Massachusetts Mutual Life Insurance Company governing the issuance of (1) $50.0 million in aggregate principal amount of Series A senior unsecured notes due August 2025 (the “Series A Notes due 2025”) with a fixed interest rate of 4.66% per year, and (2) up to $50.0 million in aggregate principal amount of additional senior unsecured notes due August 2025 with a fixed interest rate per year to be determined (the “Additional Notes” and, collectively with the Series A Notes due 2025, the “August 2025 Notes”), in each case, to qualified institutional investors in a private placement. An aggregate principal amount of $25.0 million of the Series A Notes due 2025 was issued on September 24, 2020 and an aggregate principal amount of $25.0 million of the Series A Notes due 2025 was issued on September 29, 2020, both of which will mature on August 4, 2025 unless redeemed, purchased or prepaid prior to such date by us in accordance with their terms. Interest on the August 2025 Notes is due semiannually in March and September, beginning in March 2021. In addition, we are obligated to offer to repay the August 2025 Notes at par (plus accrued and unpaid interest to, but not including, the date of prepayment) if certain change in control events occur. Subject to the terms of the August 2020 NPA, we may redeem the August 2025 Notes in whole or in part at any time or from time to time at our option at par plus accrued interest to the prepayment date and, if redeemed on or before November 3, 2024, a make-whole premium. The August 2025 Notes are guaranteed by certain of our subsidiaries, and are our general unsecured obligations that rank pari passu with all outstanding and future unsecured unsubordinated indebtedness issued by us.

On November 4, 2020, we amended the August 2020 NPA to reduce the aggregate principal amount of unissued Additional Notes from $50.0 million to $25.0 million.

The August 2020 NPA contains certain representations and warranties, and various covenants and reporting requirements customary for senior unsecured notes issued in a private placement, including, without limitation, affirmative and negative covenants such as information reporting, maintenance of our status as a BDC within the meaning of the 1940 Act, certain restrictions with respect to transactions with affiliates, fundamental changes, changes of line of business, permitted liens, investments and restricted payments, minimum shareholders’ equity, maximum net debt to equity ratio and minimum asset coverage ratio. The August 2020 NPA also contains customary events of default with customary cure and notice periods, including, without limitation, nonpayment, incorrect representation in any material respect, breach of covenant, cross-default under our other indebtedness or that of our subsidiary guarantors, certain judgements and orders, and certain events of bankruptcy. Upon the occurrence of an event of default, the holders of at least 66-2/3% in principal amount of the August 2025 Notes at the time outstanding may declare all August 2025 Notes then outstanding to be immediately due and payable. As of June 30, 2022, we were in compliance with all covenants under the August 2020 NPA.

The August 2025 Notes were offered in reliance on Section 4(a)(2) of the Securities Act of 1933, as amended (the “Securities Act”). The August 2025 Notes have not and will not be registered under the Securities Act or any state securities laws and, unless so registered, may not be offered or sold in the United States except pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the Securities Act, as applicable.

As of June 30, 2022, the fair value of the outstanding August 2025 Notes was $47.5 million. The fair value determination of the August 2025 Notes was based on a market yield approach and current interest rates, which are Level 3 inputs to the market yield model.

#### November Notes

On November 4, 2020, we entered into a Note Purchase Agreement (the “November 2020 NPA”) governing the issuance of (1) $62.5 million in aggregate principal amount of Series B senior unsecured notes due November 2025 (the “Series B Notes”) with a fixed interest rate of 4.25% per year and (2) $112.5 million in aggregate principal amount of Series C senior unsecured notes due November 2027 (the “Series C Notes,” and, collectively with the Series B Notes, the “November Notes”) with a fixed interest rate of 4.75% per year, in each case, to qualified institutional investors in a private placement. Each stated interest rate is subject to a step up of (x) 0.75% per year, to the extent the applicable November Notes do not satisfy certain investment grade conditions and/or (y) 1.50% per year, to the extent the ratio of our secured debt to total assets exceeds specified thresholds, measured as of each fiscal quarter end. The November Notes were delivered and paid for on November 5, 2020.

The Series B Notes will mature on November 4, 2025, and the Series C Notes will mature on November 4, 2027 unless redeemed, purchased or prepaid prior to such date by us in accordance with their terms. Interest on the November Notes is due semiannually in May and November, beginning in May 2021. In addition, we are obligated to offer to repay the November Notes at par (plus accrued and unpaid interest to, but not including, the date of prepayment) if certain change in control events occur. Subject to the terms of the November 2020 NPA, we may redeem the Series B Notes and the Series C Notes in whole or in part at any time or from time to time at our option at par plus accrued interest to the prepayment date and, if redeemed on or before May 4, 2025, with respect to the Series B Notes, or on or before May 4, 2027, with respect to the Series C Notes, a make-whole premium. The November Notes are guaranteed by certain of our subsidiaries, and are our general unsecured obligations that rank pari passu with all outstanding and future unsecured unsubordinated indebtedness issued by us.

The November 2020 NPA contains certain representations and warranties, and various covenants and reporting requirements customary for senior unsecured notes issued in a private placement, including, without limitation, affirmative and negative covenants such as information reporting, maintenance of our status as a BDC within the meaning of the 1940 Act, certain restrictions with respect to transactions with affiliates, fundamental changes, changes of line of business, permitted liens, investments and restricted payments, minimum shareholders’ equity, maximum net debt to equity ratio and minimum asset coverage ratio. The November 2020 NPA also contains customary events of default with customary cure and notice periods, including, without limitation, nonpayment, incorrect representation in any material respect, breach of covenant, cross-default under our other indebtedness or that of our subsidiary guarantors, certain judgements and orders, and certain events of bankruptcy. Upon the occurrence of an event of default, the holders of at least 66-2/3% in principal amount of the November Notes at the time outstanding may declare all November Notes then outstanding to be immediately due and payable. As of June 30, 2022, we were in compliance with all covenants under the November 2020 NPA.

The November Notes were offered in reliance on Section 4(a)(2) of the Securities Act. The November Notes have not and will not be registered under the Securities Act or any state securities laws and, unless so registered, may not be offered or sold in the United States except pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the Securities Act, as applicable.

As of June 30, 2022, the fair value of the outstanding Series B Notes and the Series C Notes was $58.4 million and $101.7 million, respectively. The fair value determinations of the Series B Notes and Series C Notes were based on a market yield approach and current interest rates, which are Level 3 inputs to the market yield model.

#### February Notes

On February 25, 2021, we entered into a Note Purchase Agreement (the “February 2021 NPA”) governing the issuance of (1) $80.0 million in aggregate principal amount of Series D senior unsecured notes due February 26, 2026 (the “Series D Notes”) with a fixed interest rate of 3.41% per year and (2) $70.0 million in aggregate principal amount of Series E senior unsecured notes due February 26, 2028 (the “Series E Notes” and, collectively with the Series D Notes, the “February Notes”) with a fixed interest rate of 4.06% per year, in each case, to qualified institutional investors in a private placement. Each stated interest rate is subject to a step up of (x) 0.75% per year, to the extent the applicable February Notes do not satisfy certain investment grade rating conditions and/or (y) 1.50% per year, to the extent the ratio of our secured debt to total assets exceeds specified thresholds, measured as of each fiscal quarter end. The February Notes were delivered and paid for on February 26, 2021.

The Series D Notes will mature on February 26, 2026, and the Series E Notes will mature on February 26, 2028 unless redeemed, purchased or prepaid prior to such date by us in accordance with the terms of the February 2021 NPA. Interest on the February Notes is due semiannually in February and August of each year, beginning in August 2021. In addition, we are obligated to offer to repay the February Notes at par (plus accrued and unpaid interest to, but not including, the date of prepayment) if certain change in control events occur. Subject to the terms of the February 2021 NPA, we may redeem the Series D Notes and the Series E Notes in whole or in part at any time or from time to time at our option at par plus accrued interest to the prepayment date and, if redeemed on or before August 26, 2025, with respect to the Series D Notes, or on or before August 26, 2027, with respect to the Series E Notes, a make-whole premium. The February Notes are guaranteed by certain of our subsidiaries, and are our general unsecured obligations that rank pari passu with all outstanding and future unsecured unsubordinated indebtedness issued by us.

The February 2021 NPA contains certain representations and warranties, and various covenants and reporting requirements customary for senior unsecured notes issued in a private placement, including, without limitation, information reporting, maintenance of our status as a BDC within the meaning of the 1940 Act, and certain restrictions with respect to transactions with affiliates, fundamental changes, changes of line of business, permitted liens, investments and restricted payments. In addition, the February 2021 NPA contains the following financial covenants: (a) maintaining a minimum obligors’ net worth, measured as of each fiscal quarter end; (b) not permitting our asset coverage ratio, as of the date of the incurrence of any debt for borrowed money or the making of any cash dividend to shareholders, to be less than the statutory minimum then applicable to us under the 1940 Act; and (c) not permitting our net debt to equity ratio to exceed 2.0x, measured as of each fiscal quarter end.

The February 2021 NPA also contains customary events of default with customary cure and notice periods, including, without limitation, nonpayment, incorrect representation in any material respect, breach of covenant, cross-default under other indebtedness or that of our subsidiary guarantors, certain judgements and orders, and certain events of bankruptcy. Upon the occurrence of certain events of default, the holders of at least 66-2/3% in principal amount of the February Notes at the time outstanding may declare all February Notes then outstanding to be immediately due and payable. As of June 30, 2022, we were in compliance with all covenants under the February 2021 NPA.

The February Notes were offered in reliance on Section 4(a)(2) of the Securities Act. The February Notes have not and will not be registered under the Securities Act or any state securities laws and, unless so registered, may not be offered or sold in the United States except pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the Securities Act, as applicable.

As of June 30, 2022, the fair value of the outstanding Series D Notes and the Series E Notes was $71.6 million and $60.2 million, respectively. The fair value determinations of the Series D Notes and Series E Notes were based on a market yield approach and current interest rates, which are Level 3 inputs to the market yield model.

#### November 2026 Notes

On November 23, 2021, we entered into an Indenture (the “Base Indenture”) and a Supplemental Indenture (the “First Supplemental Indenture” and, together with the Base Indenture, the “Indenture”) with U.S. Bank National Association (the “Trustee”). The First Supplemental Indenture relates to our issuance of $350.0 million aggregate principal amount of its 3.300% notes due 2026 (the “November 2026 Notes”).

The November 2026 Notes will mature on November 23, 2026 and may be redeemed in whole or in part at our option at any time or from time to time at the redemption prices set forth in the Indenture. The November 2026 Notes bear interest at a rate of 3.300% per year payable semi-annually on May 23 and November 23 of each year, commencing on May 23, 2022. The November 2026 Notes are our general unsecured obligations that rank senior in right of payment to all of our existing and future indebtedness that is expressly subordinated in right of payment to the November 2026 Notes, rank pari passu with all existing and future unsecured unsubordinated indebtedness issued by us, rank effectively junior to any of our secured indebtedness (including unsecured indebtedness that we later secure) to the extent of the value of the assets securing such indebtedness, and rank structurally junior to all existing and future indebtedness (including trade payables) incurred by our subsidiaries, financing vehicles or similar facilities.

The Indenture contains certain covenants, including covenants requiring us to comply with the asset coverage requirements of Section 18(a)(1)(A) as modified by Section 61(a)(1) and (2) of the 1940 Act, whether or not it is subject to those requirements, and to provide financial information to the holders of the November 2026 Notes and the Trustee if we are no longer subject to the reporting requirements under the Exchange Act. These covenants are subject to important limitations and exceptions that are described in the Indenture.

In addition, on the occurrence of a “change of control repurchase event,” as defined in the Indenture, we will generally be required to make an offer to purchase the outstanding November 2026 Notes at a price equal to 100% of the principal amount of such November 2026 Notes plus accrued and unpaid interest to the repurchase date.

The November 2026 Notes were offered to persons reasonably believed to be qualified institutional buyers pursuant to Rule 144A under the Securities Act and to certain non-U.S. persons outside the United States pursuant to Regulation S under the Securities Act. The November 2026 Notes have not been registered under the Securities Act or any state securities laws and may not be offered or sold in the United States absent registration or an applicable exemption from such registration requirements.

As of June 30, 2022, the fair value of the outstanding November 2026 Notes was $298.9 million. The fair value determinations of the November 2026 Notes were based on a market yield approach and current interest rates, which are Level 3 inputs to the market yield model.

#### Share Repurchases

In connection with the closing of the MVC Acquisition on December 23, 2020, we committed to make open-market purchases of shares of our common stock in an aggregate amount of up to $15.0 million at then-current market prices at any time shares trade below 90% of our then most recently disclosed NAV per share. Any repurchases pursuant to the authorized program will occur during the 12-month period that commenced upon the filing of our quarterly report on Form 10-Q for the quarter ended March 31, 2021, which occurred on May 6, 2021, and will be made in accordance with applicable legal, contractual and regulatory requirements. The MVC repurchase program terminated on May 6, 2022. During the six months ended June 30, 2022, we repurchased a total of 207,677 shares of common stock in the open market under the authorized program at an average price of $10.14 per share, including broker commissions.

In connection with the completion of the acquisition of Sierra, we committed to make open-market purchases of shares of our common stock in an aggregate amount of up to $30.0 million at then-current market prices at any time shares trade below 90% of our then most recently disclosed NAV per share. Any repurchases pursuant to the authorized program will occur during the 12-month period commencing on April 1, 2022 and are expected to be made in accordance with a Rule 10b5-1 purchase plan that qualifies for the safe harbors provided by Rules 10b5-1 and 10b-18 under the Exchange Act, as well as subject to compliance with our covenant and regulatory requirements. During the six months ended June 30, 2022, we repurchased a total of 1,309,442 shares of common stock in the open market under the authorized program at an average price of $9.93 per share, including broker commissions.

#### Distributions to Stockholders

We intend to pay quarterly distributions to our stockholders out of assets legally available for distribution. We have adopted a dividend reinvestment plan (“DRIP”) that provides for reinvestment of dividends on behalf of our stockholders, unless a stockholder elects to receive cash. As a result, when we declare a dividend, stockholders who have not opted out of the DRIP will have their dividends automatically reinvested in shares of our common stock, rather than receiving cash dividends.

We have elected to be treated as a RIC under the Code, and intend to make the required distributions to our stockholders as specified therein. In order to maintain our tax treatment as a RIC and to obtain RIC tax benefits, we must meet certain minimum distribution, source-of-income and asset diversification requirements. If such requirements are met, then we are generally required to pay income taxes only on the portion of our taxable income and gains we do not distribute (actually or constructively) and certain built-in gains. We have historically met our minimum distribution requirements and continually monitor our distribution requirements with the goal of ensuring compliance with the Code. We can offer no assurance that we will achieve results that will permit the payment of any level of cash distributions and our ability to make distributions will be limited by the asset coverage requirement and related provisions under the 1940 Act and contained in any applicable indenture or financing agreement and related supplements. In addition, in order to satisfy the annual distribution requirement applicable to RICs, we may declare a significant portion of our dividends in shares of our common stock instead of in cash. As long as a portion of such dividend is paid in cash (which portion may be as low as 20% of such dividend (and 10% of the dividend declared through June 30, 2022) under published guidance from the Internal Revenue Service) and certain requirements are met, the entire distribution will be treated as a dividend for U.S. federal income tax purposes. As a result, a stockholder generally would be subject to tax on 100% of the fair market value of the dividend on the date the dividend is received by the stockholder in the same manner as a cash dividend, even though most of the dividend was paid in shares of our common stock.

The minimum distribution requirements applicable to RICs require us to distribute to our stockholders each year at least 90% of our investment company taxable income, or ICTI, as defined by the Code. Depending on the level of ICTI and net capital gain, if any, earned in a tax year, we may choose to carry forward ICTI in excess of current year distributions into the next tax year and pay a 4% U.S. federal excise tax on such excess. Any such carryover ICTI must be distributed before the end of the next tax year through a dividend declared prior to filing the final tax return related to the year which generated such ICTI.

ICTI generally differs from net investment income for financial reporting purposes due to temporary and permanent differences in the recognition of income and expenses. We may be required to recognize ICTI in certain circumstances in which we do not receive cash. For example, if we hold debt obligations that are treated under applicable tax rules as having original issue discount (such as debt instruments issued with warrants), we must include in ICTI each year a portion of the original issue discount that accrues over the life of the obligation, regardless of whether cash representing such income is received by us in the same taxable year. We may also have to include in ICTI other amounts that we have not yet received in cash, such as (i) PIK interest income and (ii) interest income from investments that have been classified as non-accrual for financial reporting purposes. Interest income on non-accrual investments is not recognized for financial reporting purposes, but generally is recognized in ICTI. Because any original issue discount or other amounts accrued will be included in our ICTI for the year of accrual, we may be required to make a distribution to our stockholders in order to satisfy the minimum distribution requirements, even though we will not have received and may not ever receive any corresponding cash amount. ICTI also excludes net unrealized appreciation or depreciation, as investment gains or losses are not included in taxable income until they are realized.

### Recent Developments

Subsequent to June 30, 2022, we made approximately $215.4 million of new commitments, of which $171.5 million closed and funded. The $171.5 million of investments consists of $159.9 million of first lien senior secured debt investments, $10.6 million of second lien senior secured and subordinated debt investments and $1.0 million of equity investments. The weighted average yield of the debt investments was 8.2%. In addition, we funded $11.6 million of previously committed delayed draw term loans.

On August 9, 2022, the Board declared a quarterly distribution of $0.24 per share payable on September 14, 2022 to holders of record as of September 7, 2022.

### Critical Accounting Policies and Use of Estimates

The preparation of our unaudited financial statements in accordance with U.S. GAAP requires management to make certain estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses for the periods covered by such financial statements. We have identified investment valuation and revenue recognition as our most critical accounting estimates. On an ongoing basis, we evaluate our estimates, including those related to the matters described below. These estimates are based on the information that is currently available to us and on various other assumptions that we believe to be reasonable under the circumstances. Actual results could differ materially from those estimates under different assumptions or conditions. A discussion of our critical accounting policies follows.

### Investment Valuation

The most significant estimate inherent in the preparation of our financial statements is the valuation of investments and the related amounts of unrealized appreciation and depreciation of investments recorded. We have a valuation policy, as well as established and documented processes and methodologies for determining the fair values of portfolio company investments on a recurring (at least quarterly) basis in accordance with the 1940 Act and FASB ASC Topic 820, *Fair Value Measurements and Disclosures,* or ASC Topic 820. Our current valuation policy and processes were established by Barings and have been approved by the Board.

As of June 30, 2022, our investment portfolio, valued at fair value in accordance with the Board-approved valuation policies, represented approximately 191% of our total net assets, as compared to approximately 243% of our total net assets as of December 31, 2021.

Under ASC Topic 820, fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between a willing buyer and a willing seller at the measurement date. For our portfolio securities, fair value is generally the amount that we might reasonably expect to receive upon the current sale of the security. The fair value measurement assumes that the sale occurs in the principal market for the security, or in the absence of a principal market, in the most advantageous market for the security. If no market for the security exists or if we do not have access to the principal market, the security should be valued based on the sale occurring in a hypothetical market.

Under ASC Topic 820, there are three levels of valuation inputs, as follows:

*Level 1 Inputs –* include quoted prices (unadjusted) in active markets for identical assets or liabilities.

*Level 2 Inputs –* include quoted prices for similar assets and liabilities in active markets, and inputs that are observable for the asset or liability, either directly or indirectly, for substantially the full term of the financial instrument.

*Level 3 Inputs –* include inputs that are unobservable and significant to the fair value measurement.

A financial instrument is categorized within the ASC Topic 820 valuation hierarchy based upon the lowest level of input to the valuation process that is significant to the fair value measurement. For example, a Level 3 fair value measurement may include inputs that are observable (Levels 1 and 2) and unobservable (Level 3). Therefore, unrealized appreciation and depreciation related to such investments categorized as Level 3 investments within the tables in the notes to our consolidated financial statements may include changes in fair value that are attributable to both observable inputs (Levels 1 and 2) and unobservable inputs (Level 3).

Our investment portfolio includes certain debt and equity instruments of privately held companies for which quoted prices or other observable inputs falling within the categories of Level 1 and Level 2 are generally not available. In such cases, we determine the fair value of our investments in good faith primarily using Level 3 inputs. In certain cases, quoted prices or other observable inputs exist, and if so, we assess the appropriateness of the use of these third-party quotes in determining fair value based on (i) our understanding of the level of actual transactions used by the broker to develop the quote and whether the quote was an indicative price or binding offer and (ii) the depth and consistency of broker quotes and the correlation of changes in broker quotes with underlying performance of the portfolio company.

There is no single standard for determining fair value in good faith, as fair value depends upon the specific circumstances of each individual investment. The recorded fair values of our Level 3 investments may differ significantly from fair values that would have been used had an active market for the securities existed. In addition, changes in the market environment and other events that may occur over the life of the investments may cause the gains or losses ultimately realized on these investments to be different than the valuations currently assigned.

#### Investment Valuation Process

Barings has established a pricing committee that is, subject to the oversight of the Board, responsible for the approval, implementation and oversight of the processes and methodologies that relate to the pricing and valuation of assets we hold. Barings uses independent third-party providers to price the portfolio, but in the event an acceptable price cannot be obtained from an approved external source, Barings will utilize alternative methods in accordance with internal pricing procedures established by Barings' pricing committee.

At least annually, Barings conducts reviews of the primary pricing vendors to validate that the inputs used in the vendors’ pricing process are deemed to be market observable. While Barings is not provided access to proprietary models of the vendors, the reviews have included on-site walkthroughs of the pricing process, methodologies and control procedures for each asset class and level for which prices are provided. The review also includes an examination of the underlying inputs and assumptions for a sample of individual securities across asset classes, credit rating levels and various durations, a process Barings continues to perform annually. In addition, the pricing vendors have an established challenge process in place for all security valuations, which facilitates identification and resolution of prices that fall outside expected ranges. Barings believes that the prices received from the pricing vendors are representative of prices that would be received to sell the assets at the measurement date (i.e., exit prices).

Our money market fund investments are generally valued using Level 1 inputs and our equity investments listed on an exchange or on the NASDAQ National Market System are valued using Level 1 inputs, using the last quoted sale price of that day. Our syndicated senior secured loans and structured product investments are generally valued using Level 2 inputs, which are generally valued at the bid quotation obtained from dealers in loans by an independent pricing service. Our middle-market, private debt and equity investments are generally valued using Level 3 inputs.

#### Independent Valuation

The fair value of loans and equity investments that are not syndicated or for which market quotations are not readily available, including middle-market loans, are generally submitted to independent providers to perform an independent valuation on those loans and equity investments as of the end of each quarter. Such loans and equity investments are initially held at cost, as that is a reasonable approximation of fair value on the acquisition date, and monitored for material changes that could affect the valuation (for example, changes in interest rates or the credit quality of the borrower). At the quarter end following the initial acquisition, such loans and equity investments are generally sent to a valuation provider which will determine the fair value of each investment. The independent valuation providers apply various methods (synthetic rating analysis, discounting cash flows, and re-underwriting analysis) to establish the rate of return a market participant would require (the “discount rate”) as of the valuation date, given market conditions, prevailing lending standards and the perceived credit quality of the issuer. Future expected cash flows for each investment are discounted back to present value using these discount rates in the discounted cash flow analysis. A range of values will be provided by the valuation provider and Barings will determine the point within that range that it will use in making valuation recommendations to the Board, and will report to the Board on its rationale for each such determination. Barings uses its internal valuation model as a comparison point to validate the price range provided by the valuation provider and, where applicable, in determining the point within that range that it will use in making valuation recommendations to the Board. If Barings’ pricing committee disagrees with the price range provided, it may make a fair value recommendation to the Board that is outside of the range provided by the independent valuation provider, and will notify the Board of any such override and the reasons therefore. In certain instances, we may determine that it is not cost-effective, and as a result is not in the stockholders' best interests, to request an independent valuation firm to perform an independent valuation on certain investments. Such instances include, but are not limited to, situations where the fair value of the investment in the portfolio company is determined to be insignificant relative to the total investment portfolio. Pursuant to these procedures, the Board determines in good faith whether our investments were valued at fair value in accordance with our valuation policies and procedures and the 1940 Act based on, among other things, the input of Barings, our Audit Committee and the independent valuation firm.

The SEC has adopted new Rule 2a-5 under the 1940 Act. This rule establishes requirements for determining fair value in good faith for purposes of the 1940 Act. We will comply with the new rule’s valuation requirements on or before the SEC’s September 8, 2022 compliance date.

### Valuation Techniques

Our valuation techniques are based upon both observable and unobservable pricing inputs. Observable inputs reflect market data obtained from independent sources, while unobservable inputs reflect our market assumptions. Our assessment of the significance of a particular input to the fair value measurement in its entirety requires judgment and considers factors specific to the financial instrument. An independent pricing service provider is the preferred source of pricing a loan, however, to the extent the independent pricing service provider price is unavailable or not relevant and reliable, we will utilize alternative approaches such as broker quotes or manual prices. We attempt to maximize the use of observable inputs and minimize the use of unobservable inputs. The availability of observable inputs can vary from investment to investment and is affected by a wide variety of factors, including the type of security, whether the security is new and not yet established in the marketplace, the liquidity of markets and other characteristics particular to the security.

#### Valuation of Investments in Jocassee, Thompson Rivers, Waccamaw River, Sierra JV and MVC Private Equity Fund LP

As Jocassee, Thompson Rivers, Waccamaw River, Sierra JV and MVC Private Equity Fund LP are investment companies with no readily determinable fair values, we estimate the fair value of our investments in these entities using net asset value of each company and our ownership percentage as a practical expedient. The net asset value is determined in accordance with the specialized accounting guidance for investment companies.

### Revenue Recognition

#### Interest and Dividend Income

Interest income, including amortization of premium and accretion of discount, is recorded on the accrual basis to the extent that such amounts are expected to be collected. Generally, when interest and/or principal payments on a loan become past due, or if we otherwise do not expect the borrower to be able to service its debt and other obligations, we will place the loan on non-accrual status and will generally cease recognizing interest income on that loan for financial reporting purposes until all principal and interest have been brought current through payment or due to a restructuring such that the interest income is deemed to be collectible. The cessation of recognition of such interest will negatively impact the reported fair value of the investment. We write off any previously accrued and uncollected interest when it is determined that interest is no longer considered collectible. Dividend income is recorded on the ex-dividend date.

We may have to include interest income in our ICTI, including original issue discount income, from investments that have been classified as non-accrual for financial reporting purposes. Interest income on non-accrual investments is not recognized for financial reporting purposes, but generally is recognized in ICTI. As a result, we may be required to make a distribution to our stockholders in order to satisfy the minimum distribution requirements to maintain our RIC tax treatment, even though we will not have received and may not ever receive any corresponding cash amount. Additionally, any loss recognized by us for U.S. federal income tax purposes on previously accrued interest income will be treated as a capital loss.

#### Fee Income

Origination, facility, commitment, consent and other advance fees received in connection with the origination of a loan, or Loan Origination Fees, are recorded as deferred income and recognized as investment income over the term of the loan. Upon prepayment of a loan, any unamortized Loan Origination Fees are recorded as investment income. In the general course of our business, we receive certain fees from portfolio companies, which are non-recurring in nature. Such fees include loan prepayment penalties, advisory, loan amendment and other fees, and are recorded as investment income when earned.

Fee income for the three and six months ended June 30, 2022 and 2021 was as follows:

*($ in thousands)*

| Recurring Fee Income: | Three Months Ended June 30, 2022 | Three Months Ended June 30, 2021 | Six Months Ended June 30, 2022 | Six Months Ended June 30, 2021 |
| --- | ---: | ---: | ---: | ---: |
| Amortization of loan origination fees | $1,489 | $1,164 | $2,816 | $2,242 |
| Management, valuation and other fees | 633 | 547 | 47 | 1,129 |
| Total Recurring Fee Income | 2,122 | 1,711 | 2,863 | 3,371 |
| **Non-Recurring Fee Income:** |  |  |  |  |
| Prepayment fees | 133 | — | 133 | 49 |
| Acceleration of unamortized loan origination fees | 2,301 | 868 | 2,497 | 1,271 |
| Advisory, loan amendment and other fees | 516 | (11) | 775 | 10 |
| Total Non-Recurring Fee Income | 2,950 | 857 | 3,405 | 1,330 |
| **Total Fee Income** | **$5,072** | **$2,568** | **$6,268** | **$4,701** |

#### Payment-in-Kind (PIK) Interest Income

We currently hold, and expect to hold in the future, some loans in our portfolio that contain PIK interest provisions. PIK interest, computed at the contractual rate specified in each loan agreement, is periodically added to the principal balance of the loan, rather than being paid to us in cash, and is recorded as interest income. Thus, the actual collection of PIK interest may be deferred until the time of debt principal repayment.

PIK interest, which is a non-cash source of income at the time of recognition, is included in our taxable income and therefore affects the amount we are required to distribute to our stockholders to maintain our tax treatment as a RIC for U.S. federal income tax purposes, even though we have not yet collected the cash. Generally, when current cash interest and/or principal payments on a loan become past due, or if we otherwise do not expect the borrower to be able to service its debt and other obligations, we will place the loan on non-accrual status and will generally cease recognizing PIK interest income on that loan for financial reporting purposes until all principal and interest have been brought current through payment or due to a restructuring such that the interest income is deemed to be collectible. We write off any previously accrued and uncollected PIK interest when it is determined that the PIK interest is no longer collectible.

We may have to include in our ICTI, PIK interest income from investments that have been classified as non-accrual for financial reporting purposes. Interest income on non-accrual investments is not recognized for financial reporting purposes, but generally is recognized in ICTI. As a result, we may be required to make a distribution to our stockholders in order to satisfy the minimum distribution requirements, even though we will not have received and may not ever receive any corresponding cash amount.

### Unused Commitments

In the normal course of business, we are party to financial instruments with off-balance sheet risk, consisting primarily of unused commitments to extend financing to our portfolio companies. Since commitments may expire without being drawn upon, the total commitment amount does not necessarily represent future cash requirements. As of June 30, 2022 and December 31, 2021, we believed that we had adequate financial resources to satisfy our unfunded commitments. The balances of unused commitments to extend financing as of June 30, 2022 and December 31, 2021 were as follows:

| Portfolio Company ($ in thousands) | Investment Type | June 30, 2022 | December 31, 2021 |
| --- | --- | ---: | ---: |
| 1888 Industrial Services, LLC(1)(2) | Revolver | $189 | $— |
| Acclime Holdings HK Limited(1) | Delayed Draw Term Loan | — | 1,179 |
| Acclime Holdings HK Limited(1) | Delayed Draw Term Loan | — | 110 |
| Accurus Aerospace Corporation(1)(2) | Revolver | 2,305 | — |
| Air Comm Corporation, LLC(1) | Delayed Draw Term Loan | 11 | 11 |
| Air Comm Corporation, LLC(1) | Delayed Draw Term Loan | 1,448 | 1,448 |
| Amtech Software(1) | Delayed Draw Term Loan | 1,527 | 2,727 |

114

| Portfolio Company ($ in thousands) | Investment Type | June 30, 2022 | December 31, 2021 |
| --- | --- | ---: | ---: |
| Amtech Software(1) | Revolver | 682 | 682 |
| AnalytiChem Holding GmbH(1)(2)(3) | Incremental Term Loan | 917 | 6,207 |
| AnalytiChem Holding GmbH(1)(2)(3) | Bridge Revolver | 359 | — |
| Aquavista Watersides 2 LTD(1)(2)(4) | Bridge Revolver | 451 | 503 |
| Aquavista Watersides 2 LTD(1)(2)(4) | Acquisition Facility | 2,821 | 3,147 |
| Astra Bidco Limited(1)(2)(4) | Delayed Draw Term Loan | 885 | 2,571 |
| Avance Clinical Bidco Pty Ltd(1)(2)(5) | Delayed Draw Term Loan | 1,314 | 3,497 |
| Azalea Buyer, Inc.(1)(2) | Delayed Draw Term Loan | 961 | 962 |
| Azalea Buyer, Inc.(1)(2) | Revolver | 423 | 481 |
| Bariacum S.A(1)(2)(3) | Acquisition Facility | 1,986 | 2,161 |
| Beyond Risk Management, Inc.(1)(2) | Delayed Draw Term Loan | 2,423 | 2,573 |
| BigHand UK Bidco Limited(1)(2)(4) | Acquisition Facility | — | 378 |
| Black Angus Steakhouses, LLC(1) | Delayed Draw Term Loan | 417 | — |
| Bounteous, Inc.(1) | Delayed Draw Term Loan | 2,840 | 2,840 |
| Brightpay Limited(1)(2)(3) | Delayed Draw Term Loan | 197 | 432 |
| Brightpay Limited(1)(2)(3) | Delayed Draw Term Loan | 132 | 144 |
| BrightSign LLC(1)(2) | Revolver | 1,329 | 1,329 |
| British Engineering Services Holdco Limited(1)(2)(4) | Bridge Revolver | — | 613 |
| CAi Software, LLC(1)(2) | Revolver | 943 | 943 |
| Canadian Orthodontic Partners Corp.(1)(2)(6) | Delayed Draw Term Loan | 116 | 167 |
| Centralis Finco S.a.r.l.(1)(2)(3) | Acquisition Facility | 424 | 461 |
| Ceres Pharma NV(1)(2)(3) | Delayed Draw Term Loan | 1,976 | 2,149 |
| CGI Parent, LLC(1) | Revolver | 1,653 | — |
| Classic Collision (Summit Buyer, LLC)(1) | Delayed Draw Term Loan | 267 | 393 |
| Coastal Marina Holdings, LLC(1)(2) | PIK Tranche B Term Loan | 1,311 | 1,311 |
| Coastal Marina Holdings, LLC(1)(2) | Tranche A Term Loan | 3,576 | 3,576 |
| Command Alkon (Project Potter Buyer, LLC)(1) | Delayed Draw Term Loan | — | 6,018 |
| Comply365, LLC(1)(2) | Revolver | 1,100 | — |
| Coyo Uprising GmbH(1)(2)(3) | Delayed Draw Term Loan | 821 | 894 |
| Crash Champions, LLC(1)(2) | Delayed Draw Term Loan | 378 | 5,420 |
| CSL Dualcom(1)(2)(4) | Acquisition Term Loan | 895 | 998 |
| Dart Buyer, Inc.(1) | Delayed Draw Term Loan | — | 2,431 |
| DecksDirect, LLC(1)(2) | Revolver | 153 | 218 |
| DreamStart Bidco SAS(1)(2)(3) | Acquisition Facility | 567 | 617 |
| Dune Group(1)(3) | Delayed Draw Term Loan | 611 | 665 |
| Dwyer Instruments, Inc.(1)(2) | Delayed Draw Term Loan | 692 | 692 |
| Eclipse Business Capital, LLC(1) | Revolver | 6,545 | 11,818 |
| EMI Porta Holdco LLC(1) | Delayed Draw Term Loan | 10,441 | 12,458 |
| EMI Porta Holdco LLC(1) | Revolver | 2,005 | 2,966 |
| EPS NASS Parent, Inc.(1) | Delayed Draw Term Loan | 257 | 583 |
| eShipping, LLC(1) | Delayed Draw Term Loan | 1,650 | 2,548 |
| eShipping, LLC(1) | Revolver | 1,486 | 1,232 |
| Events Software BidCo Pty Ltd(1)(2)(5) | Delayed Draw Term Loan | 440 | — |
| F24 (Stairway BidCo GmbH)(1)(2)(3) | Delayed Draw Term Loan | 274 | 405 |
| Fineline Technologies, Inc.(1) | Delayed Draw Term Loan | 180 | 180 |
| Finexvet(1)(2)(3) | Acquisition Facility | 230 | — |

115

| Portfolio Company ($ in thousands) | Investment Type | June 30, 2022 | December 31, 2021 |
| --- | --- | ---: | ---: |
| Footco 40 Limited(1)(2)(4) | Delayed Draw Term Loan | 773 | — |
| FragilePak LLC(1) | Delayed Draw Term Loan | 2,354 | 2,354 |
| GPZN II GmbH(1)(2)(3) | CAF Term Loan | 549 | — |
| Heartland Veterinary Partners, LLC(1) | Delayed Draw Term Loan | 267 | 657 |
| Heavy Construction Systems Specialists, LLC(1) | Revolver | 2,632 | 2,632 |
| HW Holdco, LLC (Hanley Wood LLC)(1)(2) | Delayed Draw Term Loan | 913 | 1,563 |
| IGL Holdings III Corp.(1) | Delayed Draw Term Loan | — | 1,217 |
| Innovad Group II BV(1)(2)(3) | Delayed Draw Term Loan | 1,236 | 1,825 |
| INOS 19-090 GmbH(1)(2)(3) | Acquisition Facility | 2,331 | 2,535 |
| ITI Intermodal, Inc.(1) | Delayed Draw Term Loan | 103 | 103 |
| ITI Intermodal, Inc.(1) | Revolver | 124 | 124 |
| Jaguar Merger Sub Inc.(1)(2) | Delayed Draw Term Loan | 711 | 1,961 |
| Jaguar Merger Sub Inc.(1)(2) | Revolver | 490 | 490 |
| Jocassee Partners LLC | Joint Venture | 65,000 | 20,000 |
| Jon Bidco Limited(1)(2)(7) | Capex & Acquisition Facility | 1,416 | — |
| Jones Fish Hatcheries & Distributors LLC(1) | Revolver | 418 | — |
| Kano Laboratories LLC(1)(2) | Delayed Draw Term Loan | 2,830 | 153 |
| Kano Laboratories LLC(1)(2) | Delayed Draw Term Loan | 153 | 4,544 |
| Kemmerer Operations LLC(1) | Delayed Draw Term Loan | 908 | — |
| LAF International(1)(2)(3) | Acquisition Facility | 167 | 341 |
| Lambir Bidco Limited(1)(2)(3) | Bridge Revolver | — | 941 |
| Lambir Bidco Limited(1)(2)(3) | Delayed Draw Term Loan | 1,730 | 1,881 |
| Lattice Group Holdings Bidco Limited(1)(2) | Delayed Draw Term Loan | 354 | — |
| LeadsOnline, LLC(1) | Revolver | 2,256 | — |
| Lifestyle Intermediate II, LLC(1)(2) | Revolver | 2,333 | — |
| LivTech Purchaser, Inc.(1) | Delayed Draw Term Loan | 34 | 82 |
| Marmoutier Holding B.V.(1)(2)(3) | Delayed Draw Term Loan | 372 | 405 |
| Marmoutier Holding B.V.(1)(2)(3) | Revolver | 149 | 162 |
| Marshall Excelsior Co.(1)(2) | Revolver | 689 | — |
| MC Group Ventures Corporation(1) | Delayed Draw Term Loan | 817 | 817 |
| Modern Star Holdings Bidco Pty Limited(1)(2)(5) | Capex Term Loan | 982 | 1,038 |
| Murphy Midco Limited(1)(2)(4) | Delayed Draw Term Loan | 598 | 2,617 |
| Narda Acquisitionco., Inc.(1)(2) | Revolver | 1,311 | 1,311 |
| Navia Benefit Solutions, Inc.(1)(2) | Delayed Draw Term Loan | 1,261 | 1,261 |
| Nexus Underwriting Management Limited(1)(2)(4) | Revolver | — | 103 |
| Nexus Underwriting Management Limited(1)(2)(4) | Acquisition Facility | 447 | 541 |
| Novotech Aus Bidco Pty Ltd(1)(2) | Capex & Acquisition Facility | 809 | — |
| OA Buyer, Inc.(1)(2) | Revolver | 1,331 | 1,331 |
| OAC Holdings I Corp(1) | Revolver | 294 | — |
| OG III B.V.(1)(2)(3) | Acquisition CapEx Facility | — | 686 |
| Omni Intermediate Holdings, LLC(1)(2) | Delayed Draw Term Loan | — | 817 |
| Omni Intermediate Holdings, LLC(1)(2) | Delayed Draw Term Loan | 2,289 | 4,357 |
| OSP Hamilton Purchaser, LLC(1) | Revolver | 131 | 187 |
| Pacific Health Supplies Bidco Pty Limited(1)(5) | CapEx Term Loan | — | 1,283 |
| PDQ.Com Corporation(1) | Delayed Draw Term Loan | — | 289 |
| PDQ.Com Corporation(1) | Delayed Draw Term Loan | 7,753 | 10,948 |
| Perimeter Master Note Business Trust(1)(2) | Series 2022-One Class A | 73 | — |

116

| Portfolio Company ($ in thousands) | Investment Type | June 30, 2022 | December 31, 2021 |
| --- | --- | ---: | ---: |
| Perimeter Master Note Business Trust(1)(2) | Series 2022-One Class B | 73 | — |
| Perimeter Master Note Business Trust(1)(2) | Series 2022-One Class C | 73 | — |
| Perimeter Master Note Business Trust(1)(2) | Series 2022-One Class D | 73 | — |
| Perimeter Master Note Business Trust(1)(2) | Series 2022-One Class E | 3,709 | — |
| Polara Enterprises, L.L.C.(1) | Revolver | 474 | 545 |
| Policy Services Company, LLC(1)(2) | Delayed Draw Term Loan | — | 6,944 |
| Premium Invest(1)(2)(3) | Acquisition Facility | 1,777 | 1,933 |
| ProfitOptics, LLC(1) | Revolver | 484 | — |
| Protego Bidco B.V.(1)(2)(3) | Delayed Draw Term Loan | 776 | 844 |
| PSP Intermediate 4, LLC(1)(2)(3) | Delayed Draw Term Loan | 712 |  |
| QPE7 SPV1 BidCo Pty Ltd(1)(2)(5) | Acquisition Term Loan | — | 373 |
| RA Outdoors, LLC(1)(2) | Revolver | 1,235 | — |
| Rep Seko Merger Sub LLC(1)(2) | Delayed Draw Term Loan | 929 | 1,455 |
| Reward Gateway (UK) Ltd(1)(2)(4) | Acquisition Facility | 606 | 1,061 |
| Riedel Beheer B.V.(1)(2)(3) | Revolver | — | 230 |
| Riedel Beheer B.V.(1)(2)(3) | Delayed Draw Term Loan | 141 | 153 |
| Sanoptis S.A.R.L.(1)(3) | Acquisition Capex Facility | 7,482 | — |
| Scaled Agile, Inc.(1) | Delayed Draw Term Loan | 416 | 416 |
| Scaled Agile, Inc.(1) | Revolver | 336 | 336 |
| Scout Bidco B.V.(1)(3) | Revolver | 1,009 | — |
| Scout Bidco B.V.(1)(2)(3) | Delayed Draw Term Loan | 2,223 | — |
| Security Holdings B.V.(1)(3) | Delayed Draw Term Loan | 2,091 | 2,274 |
| Security Holdings B.V.(1)(3) | Revolver | 1,045 | 1,137 |
| Sereni Capital NV(1)(2)(3) | Revolver | 53 | — |
| Sereni Capital NV(1)(2)(3) | Term Loan | 376 | — |
| Smartling, Inc.(1) | Delayed Draw Term Loan | 1,978 | 2,353 |
| Smartling, Inc.(1) | Revolver | 1,176 | 1,176 |
| Smile Brands Group, Inc.(1)(2) | Delayed Draw Term Loan | 185 | 655 |
| Springbrook Software (SBRK Intermediate, Inc.)(1) | Delayed Draw Term Loan | — | 2,373 |
| SSCP Pegasus Midco Limited(1)(2)(4) | Delayed Draw Term Loan | 4,709 | 5,251 |
| Superjet Buyer, LLC(1) | Revolver | 1,825 | 1,825 |
| Syntax Systems Ltd(1) | Revolver | 448 | 569 |
| Syntax Systems Ltd(1) | Delayed Draw Term Loan | 1,933 | 1,933 |
| Tank Holding Corp(1) | Revolver | 509 | — |
| Techone B.V.(1)(2)(3) | Delayed Draw Term Loan | — | 1,621 |
| Techone B.V.(1)(2)(3) | Revolver | 219 | 432 |
| Tencarva Machinery Company, LLC(1) | Delayed Draw Term Loan | 886 | 886 |
| Tencarva Machinery Company, LLC(1) | Revolver | 1,129 | 1,129 |
| The Caprock Group, Inc. (aka TA/TCG Holdings, LLC)(1) | Delayed Draw Term Loan | 2,811 | 2,811 |
| The Caprock Group, Inc. (aka TA/TCG Holdings, LLC)(1) | Revolver | 827 | 827 |
| The Hilb Group, LLC(1)(2) | Delayed Draw Term Loan | 2,345 | 2,773 |
| TPC Group, Inc.(1)(2) | Revolver | 34,322 | — |
| Transit Technologies LLC(1)(2) | Delayed Draw Term Loan | — | 1,857 |
| Truck-Lite Co., LLC(1)(2) | Delayed Draw Term Loan | — | 4,540 |
| Turbo Buyer, Inc.(1) | Delayed Draw Term Loan | — | 2,070 |
| Turbo Buyer, Inc.(1) | Delayed Draw Term Loan | 2,130 | — |
| Union Bidco Limited(1)(4) | Acquisition Facility | 151 | — |

117

| Portfolio Company ($ in thousands) | Investment Type | June 30, 2022 | December 31, 2021 |
| --- | --- | ---: | ---: |
| United Therapy Holding III GmbH(1)(2)(3) | Acquisition Facility | 1,588 | — |
| USLS Acquisition, Inc.(f/k/a US Legal Support, Inc.)(1)(2) | Delayed Draw Term Loan | 3,820 | — |
| Victoria Bidco Limited(1)(2)(4) | Delayed Draw Term Loan | 423 | — |
| Waccamaw River, LLC(2) | Joint Venture | 2,480 | 11,280 |
| W2O Holdings, Inc.(1) | Delayed Draw Term Loan | 2,622 | 3,832 |
| Woodland Foods, Inc.(1) | Revolver | 1,465 | 2,070 |
| Xeinadin Bidco Limited(1)(2)(4) | CAF Term Loan | 5,986 | — |
| ZB Holdco LLC(1) | Revolver | 845 | — |
| ZB Holdco LLC(1) | Delayed Draw Term Loan | 1,352 | — |
| Zeppelin Bidco Limited(1)(2)(4) | Capex / Acquisition Facility | 2,541 | — |
| Zeppelin Bidco Limited(1)(2)(4) | Revolver | 534 | — |
| Total unused commitments to extend financing |  | $279,328 | $234,658 |

(1) Our estimate of the fair value of the current investments in these portfolio companies includes an analysis of the fair value of any unfunded commitments.

(2) Represents a commitment to extend financing to a portfolio company where one or more of our current investments in the portfolio company are carried at less than cost.

(3) Actual commitment amount is denominated in Euros. Commitment was translated into U.S. dollars based on the spot rate at the relevant balance sheet date.

(4) Actual commitment amount is denominated in British pounds sterling. Commitment was translated into U.S. dollars based on the spot rate at the relevant balance sheet date.

(5) Actual commitment amount is denominated in Australian dollars. Commitment was translated into U.S. dollars based on the spot rate at the relevant balance sheet date.

(6) Actual commitment amount is denominated in Canadian dollars. Commitment was translated into U.S. dollars based on the spot rate at the relevant balance sheet date.

(7) Actual commitment amount is denominated in New Zealand dollars. Commitment was translated into U.S. dollars based on the spot rate at the relevant balance sheet date.

In the normal course of business, we guarantee certain obligations in connection with our portfolio companies (in particular, certain controlled portfolio companies). Under these guarantee arrangements, payments may be required to be made to third parties if such guarantees are called upon or if the portfolio companies were to default on their related obligations, as applicable. As of June 30, 2022 and December 31, 2021, we had guaranteed €9.9 million ($10.3 million U.S. dollars and $11.3 million U.S. dollars, respectively) relating to credit facilities among Erste Bank and MVC Automotive Group Gmbh, or MVC Auto. We would be required to make payments to Erste Bank if MVC Auto were to default on their related payment obligations. None of the credit facility guarantees are recorded as a liability on our Unaudited and Audited Consolidated Balance Sheets. As such, the credit facility liabilities are considered in the valuation of our investments in MVC Auto. The guarantees denominated in foreign currencies were translated into U.S. dollars based on the spot rate at the relevant balance sheet date.

## Market risk

As filed, 9,968 characters.

We are subject to market risk. Market risk includes risks that arise from changes in interest rates, commodity prices, equity prices and other market changes that affect market sensitive instruments. The prices of securities held by us may decline in response to certain events, including those directly involving the companies we invest in; conditions affecting the general economy; overall market changes; global pandemics; legislative reform; local, regional, national or global political, social or economic instability; and interest rate fluctuations.

In addition, we are subject to interest rate risk. Interest rate risk is defined as the sensitivity of our current and future earnings to interest rate volatility, variability of spread relationships, the difference in re-pricing intervals between our assets and liabilities and the effect that interest rates may have on our cash flows. Changes in the general level of interest rates can affect our net interest income, which is the difference between the interest income earned on interest earning assets and our interest expense incurred in connection with our interest bearing debt and liabilities. Changes in interest rates can also affect, among other things, our ability to acquire and originate loans and securities and the value of our investment portfolio. Our net investment income is affected by fluctuations in various interest rates, including LIBOR, EURIBOR, GBP LIBOR, BBSY, STIBOR, CDOR, SOFR, SONIA, SARON and BKBM. Our risk management systems and procedures are designed to identify and analyze our risk, to set appropriate policies and limits and to continually monitor these risks. We regularly measure exposure to interest rate risk and determine whether or not any hedging transactions are necessary to mitigate exposure to changes in interest rates. As of June 30, 2022, we were not a party to any interest rate hedging arrangements.

In July 2017, the head of the U.K. Financial Conduct Authority (the “FCA”), announced that the FCA will no longer persuade or compel banks to submit rates for the calculation of LIBOR after 2021. In March 2021, the FCA confirmed that all LIBOR settings will either cease to be provided by any administrator or no longer be representative: (a) immediately after December 31, 2021, in the case of sterling, euro, Swiss franc, and Japanese yen, and the one week and two month U.S. dollar settings; and (b) immediately after June 30, 2023, in the case of the remaining U.S. dollar settings. In addition, as a result of supervisory guidance from U.S. regulators, some U.S. regulated entities ceased to enter into new LIBOR contracts after January 1, 2022. At this time, no consensus exists as to what rate or rates will become accepted alternatives to LIBOR, although the Alternative Reference Rates Committee, a steering committee convened by the Board of Governors of the Federal Reserve System and the Federal Reserve Bank of New York and comprised of large U.S. financial institutions, has recommended the use of SOFR. There are many uncertainties regarding a transition from LIBOR to SOFR or any other alternative benchmark rate that may be established, including, but not limited to, the timing of any such transition, the need to amend all contracts with LIBOR as the referenced rate and, given the inherent differences between LIBOR and SOFR or any other alternative benchmark rate, how any transition may impact the cost and performance of impacted securities, variable rate debt and derivative financial instruments. In addition, SOFR or another alternative benchmark rate may fail to gain market acceptance, which could adversely affect the return on, value of and market for securities, variable rate debt and derivative financial instruments linked to such rates. The effects of a transition from LIBOR to SOFR or any other alternative benchmark rate on our cost of capital and net investment income cannot yet be determined definitively. All of our loan agreements with our portfolio companies include fallback language in the event that LIBOR becomes unavailable. This language generally either includes a clearly defined alternative reference rate after LIBOR’s discontinuation or provides that the administrative agent may identify a replacement reference rate, typically with the consent of (or prior consultation with) the borrower. In certain cases, the administrative agent will be required to obtain the consent of either a majority of the lenders under the facility, or the consent of each lender, prior to identifying a replacement reference rate. In addition, any further changes or reforms to the determination or supervision of LIBOR may result in a sudden or prolonged increase or decrease in reported LIBOR, which could have an adverse impact on the market value for or value of any LIBOR-linked securities, loans, and other financial obligations or extensions of credit held by or due to us and could have a material adverse effect on our business, financial condition and results of operations.

The U.S. Federal Reserve is currently embarking on an aggressive campaign of raising interest rates to address significant and persistent inflation. The goal of these interest rate increases is to slow economic growth and reduce price pressure. There is a significant chance that this central bank tightening cycle could force the U.S. into a recession, as which point interest rates and base rates would likely decrease. A prolonged reduction in interest rates will reduce our gross investment income and could result in a decrease in our net investment income if such decreases in SOFR are not offset by a corresponding increase in the spread over SOFR that we earn on any portfolio investments, a decrease in in our operating expenses, including with respect to our income incentive fee, or a decrease in the interest rate of our floating interest rate liabilities tied to SOFR.

As of June 30, 2022, approximately $1,921.4 million (principal amount) of our debt portfolio investments bore interest at variable rates, which generally are LIBOR-based (or based on an equivalent applicable currency rate), and many of which are subject to certain floors. A hypothetical 200 basis point increase or decrease in the interest rates on our variable-rate debt investments could increase or decrease, as applicable, our investment income by a maximum of $38.4 million on an annual basis.

Borrowings denominated in U.S. Dollars under the February 2019 Credit Facility bear interest, subject to our election, on a per annum basis equal to (i) the alternate base rate plus 1.25% (or 1.00% for so long as we maintain an investment grade credit rating) or (ii) the term Secured Overnight Financing Rate (“SOFR”) plus 2.25% (or 2.00% for so long as we maintain an investment grade credit rating) plus a credit spread adjustment of 0.10% for borrowings with an interest period of one month, 0.15% for borrowings with an interest period of three months or 0.25% for borrowings with an interest period of six months. The alternate base rate is equal to the greatest of (i) the prime rate, (ii) the federal funds rate plus 0.5%, (iii) the Overnight Bank Funding Rate plus 0.5%, (iv) one-month term SOFR plus 1.0% plus a credit spread adjustment of 0.10% and (v) 1.0%. For borrowings denominated in certain foreign currencies other than Australian dollars, the applicable currency rate for the foreign currency as defined in the credit agreement plus 2.00% (or 2.25% if we no longer maintain an investment grade credit rating) or for borrowings denominated in Australian dollars, the applicable Australian dollars Screen Rate, plus 2.20% (or 2.45% if we no longer maintain an investment grade credit rating). A hypothetical 200 basis point increase or decrease in the interest rates on the February 2019 Credit Facility could increase or decrease, as applicable, our interest expense by a maximum of $16.3 million on an annual basis (based on the amount of outstanding borrowings under the February 2019 Credit Facility as of June 30, 2022). We pay a commitment fee of (x) 0.5% per annum on undrawn amounts if the unused portion of the February 2019 Credit Facility is greater than two-thirds of total commitments or (y) 0.375% per annum on undrawn amounts if the unused portion of the February 2019 Credit Facility is equal to or less than two-thirds of total commitments.

Because we have previously borrowed, and plan to borrow in the future, money to make investments, our net investment income will be dependent upon the difference between the rate at which we borrow funds and the rate at which we invest the funds borrowed. Accordingly, there can be no assurance that a significant change in market interest rates will not have a material adverse effect on our net investment income. In periods of rising interest rates, our cost of funds would increase, which could reduce our net investment income if there is not a corresponding increase in interest income generated by our investment portfolio.

We may also have exposure to foreign currencies related to certain investments. Such investments are translated into U.S. dollars based on the spot rate at the relevant balance sheet date, exposing us to movements in the exchange rate. In order to reduce our exposure to fluctuations in exchange rates, we generally borrow in local foreign currencies under the February 2019 Credit Facility to finance such investments. As of June 30, 2022, we had borrowings denominated in Swedish kronas of 12.8kr million ($1.2 million U.S. dollars) with an interest rate of 2.250%, borrowings denominated in British pounds sterling of £77.6 million ($94.2 million U.S. dollars) with an interest rate of 2.972%, borrowings denominated in Australian dollars of A$53.1 million ($36.5 million U.S. dollars) with an interest rate of 2.780% and borrowings denominated in Euros of €138.6 million ($144.9 million U.S. dollars) with an interest rate of 2.000%.

## Controls and procedures

As filed, 1,813 characters.

### Evaluation of Disclosure Controls and Procedures

We maintain disclosure controls and procedures that are designed to ensure that information required to be disclosed in the reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms and that such information is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure. Our Chief Executive Officer and Chief Financial Officer carried out an evaluation of the effectiveness of the design and operation of our disclosure controls and procedures as of the end of the period covered by this report. Based on the evaluation of these disclosure controls and procedures, the Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures were effective as of June 30, 2022. It should be noted that any system of controls, however well designed and operated, can provide only reasonable, and not absolute, assurance that the objectives of the system are met. In addition, the design of any control system is based in part upon certain assumptions about the likelihood of future events. Because of these and other inherent limitations of control systems, there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions, regardless of how remote.

### Changes in Internal Control Over Financial Reporting

There were no changes in our internal control over financial reporting during the second quarter of 2022 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

## Risk factors

As filed, 1,248 characters.

You should carefully consider the risks described in Item 1A entitled "Risk Factors" in Part 1 of our Annual Report on Form 10-K for the year ended December 31, 2021, which was filed with the SEC on February 23, 2022, and all other information contained in this Quarterly Report on Form 10-Q, including our interim financial statements and the related notes thereto, before making a decision to purchase our securities. The risks and uncertainties referenced herein and in our most recent Annual Report on Form 10-K are not the only ones facing us. Additional risks and uncertainties not currently known to us or that we currently deem to be immaterial also may have a material adverse effect on our business, financial condition and/or operating results, as well as the market price of our securities.

There have been no material changes during the three months ended June 30, 2022 to the risk factors previously disclosed in our Annual Report on Form 10-K for the year ended December 31, 2021. If any of such risks actually occur, our business, financial condition or results of operations could be materially adversely affected. If that happens, the market price of our securities could decline, and you may lose all or part of your investment.

Filed Aug 9, 2022.
Source: SEC EDGAR, the filing index for accession 0001379785-22-000032. Last ingested by Listed: Nov 9, 2026, 19:13 ET. No prices; not investment advice.
